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ABSTRACT
STEVEN PREISSLER. Aeromycologic Survey of a Specialized Patient Care
Facility in a Hospital. (Under the direction of David A. Fraser)
A four-month, aeromycologic survey of a specialized patient care
facility in a hospital was performed. The results of 446, two-stage
impactor samples demonstrated the readiness of the facility for patient
occupancy, and the effectiveness of the engineering controls.
Furthermore, it was established, for the first time, that the likelihood
of detecting fungal colony forming units in the patient room increased
with the number of room occupants.
A single compartment model was used to rank the relative
effectiveness of the engineering controls. The filters of the air
handling unit were found to control fungal particles better than the
recirculating room HEPA filter and the positive air pressure barrier.
The limits of this agar impaction technique are discussed; also, a plan
for further research, intended to contribute to better patient dose
estimation and control, is presented.
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^0.     INTRODUCTION
#
Imagine an apple  tree in September.     On one of  the houghs  Is a bigapple.    A sudden gust of wind dislodges  the apple,  luhich falls and  killsa small mouse idiich was running about  in the grass.
If you investigate  the cause of death of  the mouse you run intodifficulties.
-K.C. Winkler (112). from Jordan
Is the apple the cause of death? If it was the act of falling, the
wind is the cause of the mouse's death.  Maybe it was the lack of
rainfall that summer which weakened the apple's attachment to the tree.
But after all, fruit grows, gravity attracts, winds blow, and summer
rainfall varies.  If assigning cause (and Science) is not folly, then we
must accept the notion that events are often the result of the combined
forces of multiple causes. We should also note that the event may not
be a unique result of combined forces.  Had there been more rainfall
that summer and the apple's attachment to the bough greater, a stronger
wind may have dislodged the fruit with the same result.
Similar difficulties are encountered when assigning cause to deaths
of hospital patients due to fungal infections. Outbreaks of nosocomial
fungal infections have been associated with many different factors. An
important factor is the concentration of fungal spores in the air.
Frequently, occurrences of pulmonary mycoses have been associated with
an absent, inadequate, or malfunctioning ventilation system.
In this report we propose a. sampling strategy to identify factors
associated with different levels of fungal spore concentration. Our
method was applied to a specialized patient care unit in a hospital
where fungal infections can be crucial.
This report is divided into six sections.  The role of fungi in
hospital infections is discussed in the first section.  The specialized
patients care area will be described in the second section with emphasis
on the ventilation system. The goals of the survey are presented in
this section.  The sampling method will be explained in the third
section. The fourth section contains summaries of the sampling results,
assembled to identify factors associated with changes in contEiminant
concentration.  General conclusions are presented in the fifth section
with a discussion of the selected issues associated with the study
results.  The last section contains recommendations for further
research.  References and appendices follow the last section.
1. FUNGI & HOSPITAL INFECTIONS
Fungal orgainisms comprise a diverse kingdom of orgemisms important
in completing the elemental cycle of carbon, by decomposing organic
carbon to inorganic carbon (C0„). This kingdom has demonstrated the
ability to survive, grow, and reproduce throughout a wide range of
envirormiental conditions, using an equally wide range of nutrient
substrates.  Fungi assimilate substrate nutrients and liberate airborne
spores or conidia to reproduce.  These qualities provide the basis for
the wide occurrence of detrimental effects of fungi: biodeterioration of
materials, products, and food; toxicoses; allergies; and mycotic
Infections.
1.1 Tvpes of Infection: Mycotic infections may result from endogenous
or exogenous fungi. Specialized, natural fungal flora of the skin or
mucous membranes, like Microsporum, Trichophyton, Epidermophyton,
Geotrtchum, and Candida,  cause diseases which are spread by direct or
indirect contact between infected and non-infected individuals. These
diseases are prevalent, mild, and seldom cause death.
On the other hand, exogenous fungi are unspecialized, free-living
saprophytes. As natural inhabitants of the soil, they are rarely
transmitted person to person. These fungi may be introduced into the
host by trauma or injury.  This results in subcutaneous infections or
# mycotic mycetomas by a. variety of dematlaceous fvmgl (chromoblasto—mycoses, and phaeohyphomycoses), Rhinosporidium seeberi
(rhinosporodioses), Lohcxi loboi  (lobomycoses), or Sporothrix shencfeii
(sporotrichoses) (88).  Airborne spores or conidia of exogenous fungi
may also enter the respiratory tract and cause pulmonary mycoses.
Airborne spores may infect normal or immunocompromised hosts.
Diseases of the normal hosts include: histoplasmoses, blastomycoses,
coccidiomycoses, and paracoccidioidomycoses. The etiologic agents
associated with these diseases show important common characteristics:
geographic restriction, dimorphism (as yeasts or spherioles), as well as
infections resulting in benign granulomas.  Diseases of normal hosts
have a high prevalence and although usually a low fatality in endemic
areas, secondary, progressive infections may be fatal.
1.2 Opportunistic Infection:  Unlike agents infecting normal hosts, the
airborne agents associated with opportunistic fungal infections are
unspecialized, ubiquitous saprotrophs which may cause progressive
disease.  If the fungal orgemism can overcome the body's defense
mechanisms and tolerate the temperature of the human body, they
encounter abundant water, high carbohydrate levels, and available
nitrogen sources.  Air-transmitted exogenous fungi which have been
associated with opportunistic infections are listed in Table 1.
An individual's intrinsic susceptibility to infection is influenced
by factors such as age, sex, pregnancy, nutrition, emd immune status.
Congenital £ind acquired diseases may lower an individual's ability to
resist fungal infection.  Immunosuppression may also result as a side
effect of medical treatments or the purposeful dimunition of the host's
immuniologic response.  Diseases and medical treatments which have been
# TABLE 1. AIRBORNE EXOGENOUS FUNGI ASSOCIATED WITH OPPORTUNISTIC
INFECTIOff (44)
Phylum
Class, Order, Family
Genus and Species
Zygomycota
Zygomycetes, Mucorales, Mucoraceae
Mucor
Shizo-pas  oryzae
R. rhizapodiformis
R.   indicus
Fhizomucor  pustllus
Absidia corymbifera
Mortierella
Basldiobolus haptosporus
Zygomycetes, Mucorales, Cunninghamellaceae
Cunninghamella elegans
Dikaryomycota
Ascomycetes, Aspergillales, Microascoceae
Petriellidium.  boydll
Basidiomycetes
Cryptococcus neoformons
(Deuteromycota)
Deuteromycetes, MoniHales, Cryptococcaceae
Ehodotorula rubra
Trichosporon cutaneum
T.   capi latum.
Deuteromycetes
Aspergillus fumigatus
A. flauus
A. glaucus
PeniciIlium
Fusariujji
Geotrichum candidum.
Helminthosporium.
Cephalosporium
Microsporum audouinii
Cladosporium. trichoides
C.   cladosporioides
Sporothrix schenckii
formally called Allescheria boydii. perfect stage of Monosportum
apiospermum
•
shown to contribute to air—transmitted opportunistic fvtngal infections
are shown in Table 2.
TABLE 2. MEDICAL HOST FACTORS ASSOCIATED WITH AIR-TRANSMITTED FUNGAL
INFECri(»( (98).
Fungi Disease Defect, Medicants, Procedures
Aspergillus
Cryptococcus
Mucor
Zygomycetes
Chronic granulomatous
disease
Rheumatoid lung
Leukemia during therapy
Bronchiectasis
Diabetes mellitus
Hodgkin's disease
Sarcoidosis
Adrenal hyperplasia?
Leukemia during therapy
Polymorphonuclear leukocyte
defect
Corticosteriod therapy
Antibiotic treatment
Cardiac surgery
Defect in cell-mediated
immuni ty
Corticosteroid therapy
Immunosuppressive therapy
Diabetes mellitus Polymorphonuclear leukocyte
Burns defect
Leukemia during therapy Parenteral drug use
Chronic pulmonary disease Severe malnutrition
Renal acidosis
1.3 Infection Tremsmission:  Transfer of the fungal agent from its
natural (or present) habitat to the compromised host has been documented
in several episodes in which a sudden increase in infection has been
detected. In 17 outbreaks shown in Table 3, an absent, inadequ- ate, or
faulty ventilation system has been identified facilitating the agent
transfer to the host.  Ten outbreaks were traced to an inside source.
An extramural source of the pathogenic fungus was identified in seven
outbreaks. Aspergillus fumigatus is the agent usually associated with
these mycotic infection epidemics.
1.4 Nosocomial Infections:  Hospitals host a unique population
requiring the need for prevention of opportunistic infections.  In the
mid-1970's, the rate of nosocomial infections in acute care, U.S.
hospitals was estimated to be 5.7 per 100 admissions (45).  The
TABLE 3.    OUTBREAKS OF AIR-TRANSHITTED FUNGAL INFECTICW WITH OMmilBUTING FACTORS
Site of Mycotic
Outbreak (Reference)____ Cases
Veterans' Administration       3
Hospital of Buffalo, NY (39)
Baltimore City Hospital (24)    4
Minneapolis 3
Veterans' Hospital (61)
Indianapolis 3
Veterans' Hospital (11)
Texas Childrens' Hospital (67) 5
9Yale University
Medical Center (42,76)
Milwaukee County
Medical Center (62)
10
Patients' Predis-
posing Condition Fungi Source of Fungi
Open heart surgery  AFu Pigeon excreta
Renal transplant    AFu Pigeon excreta
Renal transplant    AFu Pigeon excreta
University of Maryland (2)     8   Leukemia AFl   Fireproofingmaterial
Renal treinsplant    AFl   Ceiling dust
Leukemia Asp
Oncology patients   AFu
AFl
Renal transplant &  AFu
Oncology patients AFl
Contributing
Factor
A/C coil & filter
Construction dust?
Outside construction
A/C filters
Source near air intake
Inadequate filtration
Source near air intake
Malfunctioning exhaust
Hospital construction
Hospital construction
Malfunctioning exhaust
Hospital construction
Inadequate filtration
North Carolina 1
Memorial Hospital (94)
Hospital Clinico 3
de San Carlos (50)
Bellevue Hospital Center (59)  2
Rosewell Park 10
Memorial Institute (84,93)
Fitzsimmons Army 11
Medical Center (79)
•Hospital A' (109) 5
Childrens Hospital 6
of Pittsburgh (107)
Westminster 6
Childrens' Hospital (89)
Massachusettes 6
General Hospital (51)
Leukemia
Leukemia
AFl Outside construction
Premature infants
Marrow transplant
Malignancies and
steroids
Hematologic
malignancies
Immunocompromi sed
children
Marrow transplant
Immunocompromised
adults
RPu   Refuse container
RIn
AFu
AFl
Asp
Zyg
AFu
AFl
AFu
AFl
Ceiling dust
Road construction
Asp   Construction dust
Construction dust
Utility room?
A/C filters
Numerous ventilation
defects
Source near air intake
Inadequate filtration
Hospital construction
Inadequate filtration
Hospital construction
Hospital construction
Recirculating A/C
Inadequate filtration
Construction dust    Hospital construction
Asp   Construction dust?   Hospital construction
Asp = Aspergillus spp.; AFl = A. Flauus;  AFu = A. fumtgatus; RIn = Rhizopus Indtcus;RPu = Rhtzomucor pusillus; Zyg = Zygomycetes;
Eighteen additional patients exhibited colonization of the respiratory tract.
8five-year average nosocomial infection rate in U.S. medical centers for
the period 1980 through 1984 was 4.1 per 100 hospital discharges.  As
demonstrated by the data in Table 4. higher opportunistic infection
rates are associated with the severity of the underlying illness and the
prevalence of invasive medical procedures practiced by large teaching
hospitals in this country.  In these surveys (27-29),  the causal agent
is identified in approximately 85% of nosocomial infections. During the
period 1980-1982, fungi represented 6% of the identified nosocomial
pathogens.  In 1983 and 1984. this proportion increased to 7% and 8%,
respectively.
TABLE 4. UNITED STATTS NOSOCOMIAL INFECriON RATES (27-29)
Number of Infections per 1000 Discharges
Year       National Average In Large Teaching Hospitals
39.5
42.4
42.1
41.2
41.4
A hospital setting also provides a high potential for control of
the indoor environment. A highly trained staff, housekeeping service,
food service, central ventilation, and plumbing utilities all contribute
to this control. Additionally, prospective reimbursements paid
according to patient diagnosis have added incentives to reduce
nosocomial infections (110). These incentives remain despite efforts to
reclassify patients to a higher paying diagnosis related group (46).
1980 32.5
1981 33.7
1982 33.2
1983 32.7
1984 33.5
#2. BONE MARROW TRANSPLANT UNIT (BMTU)
On May 31, 1988, the University Medical Center opened a new bone
marrow transplant unit on the top floor of the hospital. The
surrounding medium-sized metropolitan area  lies in the eastern
piedmont plateau at 406 feet above sea level, halfway between the
Appalachian Mountains and the Atlantic coast, emd experiences a humid
subtropical climate (see Table 5).  Approximately 125,000 people live
within the 69.3 square miles of the city limits.  July is the hottest
o
month (mean temperature 78.3 F) and the wettest (mean rainfall of 5.19
inches) (41).
TABLE 5. REGIONAL CLIMATE (41)
o
Average annual temperature    59.9 F
Growing season 190-210 days
"Sunshine days" 230 days
Prevailing winds southeast at 7.7 m.p.h.
Annual average rainfall 44.88 inches
Annual average snowfall 7.5 inches
The University Medical Center is a nationally known,
not-for-profit, teaching and research hospital.  It contains 990 beds,
employs 5171 personnel, and receives nearly 34,000 admissions annually
(6).  Current nosocomial infection rates at the Medical Center and the
Duke University
Durham, North Carolina
(B
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associated proportion of identified piathogens are shown in Table 6.
Efforts of the infection control department result in a high
identification rate of bacterial and fungal infections.
TABLE 6. MEDICAL CENTER NOSOCOMIAL RATES (53)
Rate per 100      Percentage of Fungal Proportion
Year    Admissions    Pathogens Identified   of Identified Pathogens
1986        5.2           93.0% 16.6%
1987        6.6           93.2% 19.9%
1988        6.7           91.3% 19.5%
2.1 Ob.iectives of the Investigation: A four-month long survey was
conducted at the newly opened bone marrow transplant unit to determine
the efficacy of engineering controls and to assist with the clinical
assessment of risk due to fungal spore exposure. Two additional
questions were examined.  The possibility of ranking components of the
engineering design according to their importance in controlling fungal
spores and identification of other environmental factors affecting
fungal spore concentration In the patient rooms were investigated.
2.2 Risk of Fungal Infection:  High doses of alkylating agents are used
to treat advEinced, often terminal, malignEincies: carinomas, melanomas,
sarcomas, emd lymphomas.  Alkylating agents crosslink double-stranded
DNA. preventing the strands from separating for replication.  These
agents are non-specific, affecting not only the highly proliferative
cancer tissue, but also the bone marrow, lymphoblasts, mucous membranes
and skin, accounting for their immunosuppressive effects. Autologous
(self-donated) bone marrow transplantation is a treatment for the
effects of high-dose administration of alkylating agents.
The average bone marrow transplant patient In this unit requires
hospitalization for approximately one month.  During this period.
*#
#
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alkylating agent chemotherapy is generally administered 11. 8, 7. and 4
days before bone marrow reinfusion (106).  Neutropenia caused by
chemotherapy predisposes these patients to viral, bacterial, and fungal
Infections. Of primary interest to us is the prevention of airborne
fungal infection.
2.3 Infection Control Design:  Control of infection at the bone marrow
tremsplant unit is based on the broad principles of infection control:
preservation and enhancement of the patient's protective defenses,
identification and suppression of sources of the infective agent,
protective isolation, and surveillence. These principles were
considered in the design of the 3,700 square foot bone marrow transplauit
unit. A plan of the bone marrow transplant unit (BMTU) is shown in
Figure 1.
A 24 foot-long airlock separates the unit from the remaining areas
of the ninth floor. Staff and visitors don sterile gowns and disposable
booties in the gowning area.  The gowning area provides an entrance for
equipment and food; the former stored, and the latter prepared in
separate rooms.  Equipment is disinfected in the equipment room before
It is brought into the unit.  Food is freshly prepared or heated, and
known food sources of microorganisms, such as fresh raw vegetables, are
prohibited.  Visitors must wash hands with disinfectant, don gloves and
surgical masks before entering patient rooms.  Handwashing stations
adjoin the 16 patient rooms.  The ventilation system is designed to
reduce patients' exposures to airborne fungal spores.
Nearly all the transplsmt patients' time is spent in their room.
Clean air is supplied to the room and room air is continuously
recleaned.  Positive pressure prevents entry of presumably less clean
12
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Patient Rooms
BMTU Hall
Other BMTU Rooms
Nurses Stations
Equipment Room
Galley
Gowning Area
Airlock
9201-9216
9200X. 9220X. 9200Z
9217-9247A. except 9240-9242
9220 and 9223
9264
9263
9220Y
9200Y
FIGURE 1. FLOOR PLAN OF WE BMTU
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air from the bath, toilet, and unit corridor.  A short description of
the patient's room ventilation follows.
2.4 BMTU Ventilation:  Two similar. 12^Ar-ton.  air handling units. Nos.
AH-31 and AH-32. supply air to the bone marrow transplemt unit. A
schematic diagram of AH-31 is presented in Appendix A. Each air
handling vmit contains 120 square feet of pleated, glass-fiber
prefilters (NU-CAP-G; Environmental Filter Corporation of Greensboro,
NC) and post-filters (3XC-95; Cambridge Filter Corporation of Syracuse,
NY).  These filters have a combined efficiency of approximately 95%.
These air hEindling units also contain stegim humidifiers and coils for
heating and cooling the filtered, humidified air. Approximately 72% of
the air moved by AH-31 is recirculated from the hospital. The exact
percentage of recirculated air is determined by the difference in
temperature between the inside and the outside of the hospital. Cool
and warm conditioned air from AH-31 is combined in a mixing box before
it is supplied at a constant rate to the patient's room.  The amount of
air entering the patient's room when the toilet, bath, or hall door are
opened is small compared to the amount of air supplied by the mixing
box.  A diagram of the patient room air supply and exhaust is presented
in Figure 2. Note that AH-32 receives recirculated hospital air from
areas it supplies, but these airflows are not shown in the figure.
A wall-mounted HEPA filter cleans recirculated air in the patient's
room, providing approximately 39 room air changes per hour.  Air is
exhausted from the room through a celling mounted exhaust, bath exhaust,
and toilet exhaust.  The room remains at positive pressure with respect
to the hallway.  Air also leaves the room through the quarter to
three-quarter inch corridor door undercut.
Ambient
Outside
Air
/
Hospital Air
Dialysis
Areas adjacent
to BMTU
Ambient-
Outside
Air
Air Handler-31
Cold
Deck
Hot
Deck
HEPA
Mixing
Box
BMTU
Patient
Room  r
Ceiling  Bath   Toilet
Exhaust Exhaust Exhaust
Ambient
Outside
Air
FIGURE 2. AIR FLOW IN THE BMTU
14
Hospital Air
BMTU Corridor
BMTU Rooms
BMTU Airlock
Air Handler-32
Cold
Deck
(Door Swing)
BMTU
Rooms
BMTU Corridor -^ HEPA
Gowning
Area
Bath   Toilet
Exhaust Exhaust
BMTU
Air ock
Ambient
Outside
Air
Hospital
The bone marrow transplant unit corridor has a recirculating,
roof-mounted, HEPA filter providing nine air changes per hour.  The
corridor remains at positive pressure to other unit rooms and offices
(9217 - 9247A. except 9240 - 9242). galley (9263), and gowning area
(9220Y). The gowning area is likewise positive to the unit's airlock,
and the airlock is positive to the rest of the ninth floor.
##
3. SAMPLING METHOD
During the period April 25, through August 15, 1988, 446 seimples of
airborne spores were collected and analyzed from the bone marrow
transplant unit and the hospital roof using a pair of two-stage sieve
impactors (Andersen Samplers, Inc. of Atlanta, GA) and 100 mm petri
dishes filled with Sabouroud agar (Table 7).
TABLE 7.  IMPACrOR SAMPLE VARIABLES
Date and  Time of Sampling
Location and Height of Sieve Impactor
Presence of HEPA Exhaust
Number of Room Occupants
Sample Duration
Date Petri Plates were Analyzed
Identification and Number of CPU on Top Plate
Identification and Number CFU on Bottom Plate
Impactor Operator and CFU Counter
The two-stage sampler collects particles on agar medium and is a
simplified version of the six-stage Andersen impactor (8). The first
and second stages of the aluminum sampler have two hundred, 1.5 mm
o
diameter and 0.4 mm diameter holes, respectively.  The design, with 45
countersunk holes are arranged in a radial pattern which incorporates
the improvements of May (69). The design is reported to be efficient
for collecting airborne particles in the size range 0.8 to 10.5 microns
(105). Non-respirable microorganisms are collected on the first stage.
The two-stage impactor has been recommended for dilute concentrations
16
(less than 1,000 particles per cubic meter) of large particles (greater
than one micron diameter) (40). The samplers and vacuum pumps (Emerson
Model 0522-V103-G18DX) were calibrated against a dry gas meter (Singer
Model DTM-200) to pull one cubic foot of air per minute, as recommended
by Andersen.
Impacted particles were collected on Sabouroud agar, one of the
standard mediums used by medical mycologists.  In the late 1950's this
agar produced fungal colony counts similar to those from seven other
media in an outdoor comparison, using a slit sampler (90). Twenty years
later, in a similar comparison with seven media using a single stage
sieve impactor. Sabouroud agar produced among the highest CFU recovery
rates (23). It is a reproducible medium consisting of dextrose,
peptone, pancreatic digest of casein, and peptic digest of animal
tissue.  Sabouroud agar plates used in this study were prepared in the
Clinical Microbiology Laboratory of the University Medical Center, using
standard procedures outlined in Appendix B. After sample collection.
o
agar plates were incubated in the dark, at 30 C.  Colonies of fungi were
identified and counted after approximately three days.  Unlike liquid
impingement collection methods which reflect the total number of
microbes suspended in the air. the agar impaction method of collection
reflects the total number of airborne particles carrying fungi, spores.
or conidia (113). The "positive hole" colony count adjustment method
(63) was not used because it was not known whether a colony was observed
in the jethole jsattern.
Paired. 30-minute samples were collected simultaneously across
control barriers: usually in the patients' rooms and the corridor
outside the room. Longer sample periods dehydrate the agar. Shorter
17
#
sample periods were employed on the hospital roof to avoid overcrowding
of fungal colonies. Samples were also collected in the galley,
equipment room, gowning area, and airlock.  Approximately 11% of the
samples were collected outside the bone marrow transplant unit, as shown
in Table 8 .
TABLE 8. SAMPLING SITE DISTRIBUTION BEFORE AND AFTER OOCUPANCT
OF THE BKTU
Before On or after
Sampling Site Mav 31. 1988 MaY. 31. 1988 Row Totals^
BMTU Areas
Patient Room 29 145 174 (39 %)
BMTU Hall 29 136 165 (37 %)
Other Rooms - 15 15 (3.4%)
Galley and Equipment Room - 7 7 (1.6%)
Gowning Area 3 15 18 (4.0%)
Airlock 3 13 16 (3.6%)
Non-BMTU Areas
Adjacent Areas 3 5 8 (1.8%)
Roof — 43 43 (9.6%)
Total 67 (15%) 379 (85%) 446 (100%)
a.Percentage of column total given in parentheses.
^#
4.  SAMPLE RESULTS
The results of sampling are presented in Appendix D, arranged in
the order in which they are collected. In this section, summaries of
the results and conclusions will be presented.
This section includes descriptions of the prevalence of fungal
genera inside and outside the hospital. Statistics are presented for
fungal concentrations collected by location and sample period.
Abstracts of reports addressing each sample period accompany
presentation of these statistics. |
The effects of each engineering control measure on the
concentration of fungal spores in the patient room are demonstrated in
this section. The importance of each control measure were estimated and
ranked based on experimental and hypothetical conditions. The effects
of environmental factors on the concentration of fungal spores were also
investigated. The results of these investigations are presented at the
end of this section.
4.1 Types of Fungi: The genera of fungi identified in the hospital and
on the roof are summarized in Table 9. High proportions of positive
seimples in the first column is a measure of consistent recovery of the
corresponding organism. The second column shows the total number of
colony forming units (CFU) detected in the samples.
Overall. 53% of the 3,369 CFU's collected in this study remained
TABLE 9.   nivEirninr of fimci fbon 445 xhpactgr samples
a 3
Indoor Results for 330 m of air a      3Outdoor Results for 8 m of air
Positive Samples CFU Positive Samples CFU
Penicilltum
Cladosporlum
Aspergillus
Sterile Hyphae
Zygomycetes
Other Identified
Fungi Identified
Fungi Unidentified
30 (7.5)
34 (8.5)
28 (7.0)
9 (2.2)
6 (1.5)
2 (0.5)
102 (25.4)
202 (50.2)
1.262 (52.4)
2  60 (2.5)
49 (2.0)
I  25 (1.0)
8 (0.3)
6 (0.2)
1.410 (58.5)
999 (41.5)
28 (65.1)
5 (11.6)
19 (44.2)
0 (-)
6 (14.0)
0 (-)
35 (81.4)
35 (81.4)
132 (13.7)
14 (1.5)
27 (2.8)
0 (-)
6 (0.6)
0 (-)
179 (18.6)
781 (81.4)
Overgrown 1 (0.2) TMTC 5 (11.6) TMTC
Total 402 (100.0) > 2.409 (100.0) 43 (100.0) > 960 (100.0)
Parenthetical values are percentages of column totals.
Poecllomyces and Syncephalastruia
^TMTC = Too Many To Count
(0
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unidentified. Inside the hospital, 41.5% of the spores were not
identified. Outside the hospital, 81.4% were not identified. One agar
plate collected adjacent to the bone marrow transplant unit and eight
plates exposed to outside air became overgrown and the fungi could not
be counted or identified.
Hospital results were collected over a four month period and roof
samples were collected over four days. However, the results agree with
previously established indoor/outdoor fungal air quality relationships.
They are also consistent with previous surveys of the surrounding area
Euid hospital air. Cladosporium, the most frequently recovered taxa
outdoors in the United States (58), is likely to have been
underrepresented among the identified outdoor fungi in this study, due
to their relatively slower growth.
The overall hospital fungal spore concentration was 6% of the
outdoor fungal spore concentration. Previously reported fungal
concentrations using volumetric air sampling yielded "hospital to
outdoor ratios" of 2% for mesophilic and 5% for thermotolerant fungi
(66), 84% and 32% for A.fumigatus (100) , and 7% for thermophilic fungi
(52). In this study Periicillium, Cladosporium, and Aspergillus were the
most commonly collected taxa, indoors and out. Summaries of indoor air
quality (74), and indoor/outdoor relationships (15) express a similar
dominance of these genera. The types of fungi collected in this
investigation agree well with the isolates from other hospital studies
(77. 95), as well as those mentioned above (66, 100). Relative
proportions of the taxa differ, probably due to geographic and climatic
differences.  The genera collected in the hospital are similar to those
^#
#
21
obtained in a 1983 survey of molds in area homes using the gravity
settling plate collection method (14).
4.2 Spore Concentrations: Summary statistics for the areas sampled are
given in Tables 10 and 11. A log-probit plot of cumulative percent emd
CFU concentrations is provided in Appendix E. In the hospital, low
fungal spore concentrations predominate the sample results.  Forty-two
percent of the hospital samples detected no CFU's.  In contrast, outdoor
3
S£imples were all positive and ranged from 44 to 316 CFU/m .  While 30%
of the roof samples contained half of the outdoor isolates, over half of
all the indoor isolates collected on the bone marrow transplant unit and
adjacent areas are contained in just 1.5% of the samples.
Second-stage CFUs, presumed to be the respirable portion, comprise
68% of the total indoor CFUs based on a sample-weighted average. The
portion of outdoor respirable airborne spores is higher at 72%. This
value is within 1.4 standard deviations of the indoor average
proportion. When the overall proportion of respirable spores is
calculated for all s£unples, inside and out, the sample-weighted result
is 68.3% with a stemdard deviation of 3.3%. From these observations, we
conclude that the respirable proportion of the CFUs is fairly constant.
Therefore, isolates of both impactor stages were combined to report
fungal spore concentrations.
Usually the results of each stage are separated to estimate
potential harm based on lung penetration of the particles (105). Lung
penetration is not an importeuit factor in this study. Infectious
syndromes of pathogenic fungi include rhinocerebral. rhinoorbital, and
paranasal infection (13, 25. 32, 88). Invasive aspergillosis has also
been associated with prior nasal colonization which may provide the
*22
TABLE 10. NUMBER AND OfflfCENTRATICmS OF FUNGI BY SAMPLE LOCATION
Number of CFU Percentage of Concentration
Range (CFU/m )Samples Detected Respirable CFU
BMTU Areas
Patient Rooms 174 134 69% 0-36
BMTU Hall 165 1.212 67% 0-428
Other Rooms 7 13 85% 0 - 7.4
Galley and 15 407 63% 0 - 410
Equipment Room
Gowning Area 18 426 67% 1.2 - 218
Airlock 16 148 64% 0-37
Non-BMTU Areas
Adjacent Areas 7 69 56% 4.9 - 22
Roof^ 38 960 72% 44 - 316
Area results do not include one seimple with one overgrown plate.
Area results do not include five samples with eight overgrown
plates.
TABLE 11. SUMMARY STATISTICS OF FUNGAL OCMCENTRATIONS BY SAMPLE
LOCATION
Median Average Percentage of
Percentage Cone. _ Cone. „
(CFU/xn)
Seumples Containing
Sterlle 1/2 CFUs
BMTU Areas
Patient Rooms 77% 0 0.7 2.3%
BMTU Hall 19% 2.5 7.2 1.2%
Other Rooms 29% 2.5 2.3 29 %
Galley and 20% 3.7 33 6.6%
Equipment Room
Gowning Area 0% 11.5 26 38 %
Airlock 6% 9.8 11 25 %
Non-BMTU Areas
Adjacent Areas 0% 11.5 9.7 38 %
Roof^ 0% 184 144 30 %
Area results do not include one sample with one overgrown plate.
Area results do not include five samples with eight overgrown
plates.
*•
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inoculum to the lung (1. 76).  Further, the respirable portion of the
CFUs is predictable.
4.3 BMTU Design Effectiveness: The ultimate success of the bone marrow
transplant unit design can be judged by the absence of airborne fungal
infection. A safe level of fungal spore concentration exposure has not
been established for these susceptible patients. Other studies have
found reductions in area spore concentrations to be associated with a
decrease in the incidence of aspergillosis (91, 92. 94). The patients*
rooms are the cleanest area sampled in terms of: the percent of sterile
samples, the median spore concentration, the average spore
concentration, or the peak spore concentration.
The highest concentration of spores was outside, on the hospital
roof near the air handler inlets. Results are presented in Table 12.
If these data are representative of the fungal spore challenge, the
ventilation system reduced the contaminant concentration by an order of
magnitude in the bone marrow transplant unit and two orders of magnitude
in the patients' rooms.
TABLE 12. SUMMARY STATISTICS OF OUTDOOR FUNGAL CONCENTRATIONS
3
Concentration (CFU/m )
Location        Air Destination      Median Average Peak
AH-31 Inlet     BMTU Patient Rooms      173    175    316
AH-32 Inlet^    All other BMTU Areas    158    150    287
Area results do not include five samples with eight overgrown
plates.
4.4   Filter Component Analysis:   The effectiveness of the filter
components of the ventilation system can be analyzed using the summary
^•
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in Table 12. Results from the bone marrow transplant areas have been
tabulated by air handling unit and additional HEPA filtration.
Ck)ncentration ratios were calculated in the last two columns to derive
"contEuninant control" factors: the median and average roof
concentrations (from Table 12) were divided by the corresponding area
spore concentration (e.g. Contaminant Control (C. C.) Factor of the
AH-31 filter = AH-31 inlet average divided by average of isatient room
without a HEPA filter = 175/2.6 = 67). The higher the ratio, the more
protection provided by the barrier.
The C. C. Factors in Table 13 are consistent with filter rating
efficiencies and the rate of HEPA-filtered room air changes. The
efficiency (7) of the pre- and post-filters In the air handlers are
35-40% (80) and 90-95% (26) . respectively. Their combined efficiency
is expected to produce a dimensionless C. C. Factor of 15 to 33 under
conditions similar to the ASHRAE test. The increase in the C. C. Factor
to the room HEPA compared to the hall HEPA is likely due to the larger
number of air chsmges per hour in the room.
TABLE 13. CMfTAMINANT aMTROL FACTORS OF FILTER O0MPC»JENTS IN THE BKYU
3
Concentration (CFU/m
BMTU Area       Median Average
Patient Room      0      2.5
without HEPA
Patient Room      0      0.5
with HEPA
Other BMTU Areas  7.4    17.7
without HEPA
Other BMTU Areas  2.5    9.0
with HEPA
Concentration ratio of inlet spore concentration and area
concentration.
Barrier
C. C.
Median
Factor
Average
AH-31 filter
only
NA 69
AH-31 and
HEPA filter
NA 350
AH-32 filter
only
22 8
AH-32 and
HEPA filter
65 17
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The air handling units have identical filters, yet there is an
eight-fold difference in the calculated C. C. Factors. The differences
in spore challenge on the roof is less than 20%. The air handler
inlets, due to their close proximity, are likely to encounter similar
spore concentrations. This difference in C. C. Factors between filtered
air supplied by the two air handlers cannot be explained by this
analysis and suggests that the filters of AH-32 be examined for leaks.
4.5 Positive Pressure Barrier Analvsis: Less air is exhausted from the
patient rooms than is supplied creating a positive pressure air barrier.
Positive pressure air barriers, throughout the unit, are shown in Figure
3.
Areas Adjacent to the BMTU
B   ^ Gal
/
ey (9263)
G
Areas
Patient  .  BMTU  _  Gowning Area _  Airlock ,   AdjacentA - " '1 __!i_> (9220Y)    -^> (9200Y) -^^    to BMTU
"^E      JHF  \    '^ Equipment Room (9264)
Rooms  ----^> Ha
(9201-16)
Other BMTU Rooms (9217-47A except 9240-42)
FIGURE 3. DESIGN OF AIR PRESSURE DIFFERENTIALS IN THE BJCTU.
The arrows in Figure 3 identify the direction of airflow through the
unit. Air flows from the patient room to the BMTU hallway (Label A). Air
from the hallway leaves the BMTU (B), or enters other BMTU areas (Paths
C, D, E, and F). The gowning area receives air from the hallway (D),
galley (G), and equipment romm (H), before it leaves the BMTU (J), via
the airlock (I). The positive pressure is designed to preserve upstreajn
li
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areas of high air quality from conteuninated, downstream areas.
Simultaneous, paired samples on each side of the barrier test the
effectiveness of the positive pressure design.
In Table 14, results of paired, simultaneous (collected within one
hour) samples have been tabulated by airflow path. The proportion of
samples in which the downstream spore concentration exceeded the
upstream spore concentration is presented in the next to the last column
of Table 14. If up- and downstream concentrations are equal or if no
barrier exists, this proportion will be one-half. The p-value in the
last column is the binomial probability that this proportion or a
proportion of greater deviation would occur if no barrier existed (null
hypothesis).
TABLE 14.  PAIRED SAMPLE RESULTS FOR AIR FLOW ANALYSIS
Airflow Upstream Side (US)/  Number of Paired Samples US<DS
Label  Downstream Side (DS)  Total US<DS US=DS   Fraction P-value"
#
A Patient Room /
BMTU Hall
151 112 30 0.74 <io-^
B BMTU Hall /
Adjacent Areas
3 2 0 0.67 1.00
C BMTU Hall /
Galleys
7 1 1 0.14 0.22
D BMTU Hall /
Gowning Area
3 3 0 1.00 0.25
E BMTU Hall /
Equipment Room
6 1 0 0.17 0.22
F BMTU Hall /
Other BMTU Rooms
7 3 1 0.43 1.00
G Galley /
Gowning Area
4 2 0 0.50 1.00
H Equipment Room /
Gowning Area
4 4 0 1.00 0.13
I Gowning Area /
Airlock
15 3 1 0.20 0.06
J Airlock /
Adjacent Areas
5 2 0 0,40 1.00
Probability that no barrier exists. See text for details.
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Two airflow jjaths demonstrate an effective barrier at the 0.1
significance level, eight do not.  A significant barrier exists between
the patient room and the BMTU hallway.  A significant barrier is also
detected between the gowning area and the airlock, but air flows from an
area of high spore concentration to an area less contaminated.  At least
five paired observations are necessary to demonstrate a significant
barrier at the 90% confidence level.  The reinking of the effectiveness
of the positive pressure barriers below is based on the probabilities in
Table 14. Underlined air flow labels indicate the barrier direction was
reversed.  That is, air flowed more often from a contaminated area to a
cleaner one.
Significant =A>I>H>C,  E>D>G>B, F, J=no barrier
barrier detected
4.6 Patient Risk Assessment: Air sampling results from this study have
been reported previously to assist in assessing patient risk to fungal
spore exposure (33-35). Specifically, the following questions were
addressed: Are fungal spore levels low enough in the newly constructed
bone marrow transplant unit to transfer patients from the old unit?
Have fungal spore levels remained at an acceptable level after patients
and staff have occupied the unit? Are concentrations of fungal spores
in the hallway of the unit low enough to allow patients to enter and
remain in the hallway?
Portions of the data from the above mentioned reports are
reproduced in Table 15. Results of air samples collected between July
19. and August 15, 1988, are also summarized in this table. Comments on
each seimpling period will follow.  The new bone marrow transplant unit
TABLE 15. SUmiASy' MEASURES FOB FOUR SAMPLING PERICffiS
Number of
Volume
Sampled
(m )
Number Median Average
Location Number of Sterile au Cone. „
iCbV/va)
Cone. „
(ClU/m )Samples Samples Detected
April 25 to May 30. 1988
Patient Rooms 29 21 29.7 62 0 2.09
BMTU Hall 31 10 31.7 82 2.45 2.58
All BMTU Lor«.tions 66 32 67.6 208 1.23 3.08
May 31 to June 17. 1988
Patient Rooms 62 46 63.2 32 0 0.51
BMTU Hall 59 9 60.2 243 2.45 4.04
All BMTU Locations 129 38 131.6 340 1.23 2.58
June 20 to July 15. 1988
Patient Rooms 36 28 36.9 19 0 0.52
BMTU Hall 31 9 31.8 90 2.45 2.83
All BMTU Locations 72 38 74.0 219 0 2.96
July 19 to August 15. 1988
Patient Rooms 47 37 49.0 21 0 0.43
BMTU Hall 44 4 44.8 797 3.68 17.79
All BMTU Locations 127 44 130.4 1.573 1.23 12.07
April 25 to Avigust 15. 1988
Patient Rooms 174 132 178.8 134 0 0.75
BMTU Hall 165 32 168.5 1.212 2.45 7.19
All BMTU I,ocations 394 169 403.5 2.340 1.23 5.80
^
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opened on May 31, 1988, which was the first day of the second sampling
period.
4.7 Preoccupancy Results: Preoccupancy samples were collected where
fungal spores were thought most likely to infiltrate from outside the
unit and near the nurse's station in the center of the unit. Workmen
made final adjustments to the ventilation system and electrical
utilities during this period. Forty-eight percent of the samples
collected on the unit showed no fungal growth. Of critical importance,
only two Aspergillus spores, were detected, in the gowning area. No
other pathogenic species were detected in the unit. The gowning area
average spore concentration was five times the overall unit average
during this period.
4.8 Early Occupancy Results: During the second sampling period of
early unit occupancy, all rooms were surveyed. Of the samples collected
during this period, 42% showed no fungal growth. As seen in Table 14
(page 26), room, hall, and overall unit median values remained
vmchanged. The average concentration for the room decreased £uid the
hall average increased. The gowning area average remained at five times
the overall unit average. The overall average spore concentration for
the unit decreased but a significant increase in Aspergillus spores was
observed.
Aspergillus spores were detected seven times more frequently during
this early occupancy period compared to the preoccupancy period. Four
A. flauus spores were collected between rooms 9213 and 9216 in the hall
on four different days. One A. niger isolate was detected in room 9201,
and twice in the hall: near room 9202 four days later, and near room
9207 six days after.  Nineteen other Aspergillus spp. (not flauus.
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fumigatus, or nlger) were detected in the hall between the stairway door
and the exit to 9300 on six different days.
4.9 Later Occupancy Results: The average found in the hall decreased
during the third sampling period with little change in the other summary
statistics. Fifty-two percent of the unit samples were sterile.
Aspergtllus recovery rates decreased to the preoccupancy level. Three
species were recovered in the hall on three different days: A. flauus
near 9210, A. niger near 9207. £ind one species (not flauus, fumigatus or
terrlus) was recovered just beyond the gowning area. The gowning area
average doubled, increasing to more than ten times the unit average.
Patients were allowed to enter the hall for short periods of time
(30 minutes, twice daily). The benefits of exercise and release from
room confinement were regarded to exceed the fungal spore exposure risk.
Based on results from the three sampling periods, the hall average is
four times greater than the room average spore concentration. The
resultant total spore exposure for a 24 hour period is expected to
increase by one eighth:
23 hr. (room cone.) + 1 hr. (4 x room cone.) _ i loc
24 hr. (room cone.) ~ *   *
The proportionate increase in exposure to Aspergillus spp. is much
greater.
4.10 New Occupancy Results: Hall and overall averages for the seunpling
period from July 19, to August 15, 1988 show a marked increase compared
to the previous seimpling period. These higher values result from
Incidences of brief, steep increases in Penlcilltum spore
concentrations. The treinsitory increases occurred in the same area,
near the galley on July 28, and July 29, 1988.  Increases of this nature
*•
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have been documented during bedmaking (99), cleaning of overhead light
fixture (86), and from rotting cabinet wood on other bone marrow
transplant units (102).  The values in the table can be recalculated
without the results from these two incidences (Sample Nos. 329 to 346).
3
The new hall and overall averages are 3.8 and 2.9 CFU/m , respectively.
3The hall median decreases to 2.45 CFU/m and the overall median for the
3
sample period remains 1.23 CFU/m .
The new hall average for the last sampling period remains elevated
compared to the previous sampling period. Only 39% of the samples
detected no fungal growth. The gowning area average concentration
decreased from the previous sampling period. This average also
decreased relative to the overall average. Similar to the second
sampling period, the increase in hall average was accompanied by an
increase in the detection rate of Aspergillus species.
A total of 15 CFUs of Aspergillus spp. were detected during the
last sampling period. An A. niger species was detected in room 9212.
Nine species were detected in the hall on six different days, including
A. terrlus on July 28, 1988. A total of five Aspergillus species were
detected in the airlock, gowning and galley areas on three days.
Including A. flauus in the galley on August 1, 1988.
4.11 Baseline Concentrations: A summary of results for the complete
survey divided by room, hall, and all locations are found on the bottom
of Table 14. These values can be used as a basis of comparison for
future air sampling results. The values listed in the table illustrate
the amount of variation that might be expected from further sampling.
Concentration of spores in the patients' rooms remained low after
unit occupancy.  The average of all patient room samples after the unit
h•
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3opened is 0.48 CFU/m and only two Aspergillus spores were detected in
149 cubic meters of air sampled. It is important to note that no cases
of fvmgal infection have been observed in the BtfTU since It was opened.
Therefore, it seems that the concentrations reported may approach an
acceptable level.
3
The post-occupancy hall spore concentration is 8.3 CFU/m  and
3
without the excursions of Penicilltum is 3.7 CFU/m .  The hall sampling
results vary more than the patient room concentrations. The incidence
of Aspergillus collection is also greater but remains infrequent.
Similar concentrations of Aspergillus have been experienced in patient
rooms on the Minnesota bone marrow transplant unit (86).
4.12 Ranking of Engineering Controls: Earlier in this chapter,
effectiveness was demonstrated for each component of the engineering
design : air handler filtration, recirculating HEPA filtration, and the
positive pressure barrier between patient room and hallway. Two sources
of difficulties arise when ranking the components of the unit
engineering design by their importance in controlling fungal spore
concentrations in the patient room. Conditions of spore challenge to
the hospital unit chamge, sometimes very suddenly; roof and hall spore
concentrations ranged one and two orders of magnitude in this study.
The present set of conditions may rely on controlling a different source
of spores than a future set of conditions. Also, in this study, no
experimental controls existed to compare the lack of a positive pressure
barrier and the absence of filtration on the air handling units.
Engineering controls can be ranked in their effectiveness if
hypothetical conditions are considered. The positive effect of each
component of the engineering design has been already demonstrated in an
•^
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earlier part of this section. We can rank the contributions of the
parts of the engineering design by examining the expected effects of
removing a single component or two components under conditions already
found to exist during this study.
4.13 One Component Removal: A positive pressure barrier would not
exist if the doors to the patient rooms were removed. Over time, the
only difference in patient room and hall spore concentration would
result from lack of air mixing. The ratio of hall to room concentration
averages from bottom of Table 15 (page 28) is approximately ten. The
combined volume of the patient rooms is twice the hall volume. Assuming
perfect mixing, the patient room spore concentration would increase
four-fold, based on a volume-weighted concentration:
2(room cone.) + 1(10 x room cone.)   .—*--------'  ^ /"^-----------^ = 4 room cone.
If the filters in AH-31 were removed, the room spore concentration
would equal 28% of the roof spore concentration. This assumes that the
behavior of the room spore concentration can be accurately described by
steady state conditions of a single compartment model and that any
losses in the other components of the ventilation system are negligible.
In 1946, Lidwell and Lovelock first proposed this single
compartment model to describe the concentration of a tracer
(2,4-pentanedione) in a room (65). More recently, Rhame (85) suggested
such a model when considering the concentration of fungal spores in
patient rooms on bone marrow transplant units.
After Ishizu (54), the amount of indoor pollution (fungal spores)
can be derived from the following mass balance equation:
^*
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VdC = Gdt + Cm Q.dt - C m Q.  dt - C m Q gdt11 1 r
3
where V = volume of the room (m ).
t = time (hour),
3
C = room spore concentration at any time (CFU/m ),
3
C = inlet spore concentration supplied to the room (CFU/m ),
G = spore generation rate inside the room (CFU/hr),
3
Q. = inlet volume rate supplied to the room (m /hr).
3
Q = volume rate of recirculating filter (m /hr).
I = efficiency of filter recirculating air (dimensionless).
smid m  = mixing factor (dimensionless).
Integrating with the boundary conditions C = C , the initial spore
3
concentration (CFU/m ) at t = 0, we obtain
fli C. Q. + G
C = C exp{-ffl(Q. + S Q  )t/V} +-------—--------- [l-exp{-fl.(Q. + S Q  )t/V}].
° 1     r       m{Q.+&  Q ) i     r1   r
When the generation rate, inlet spore concentration, filter efficiency,
and volumetric flow rates remain constant, over a long period of time
the exponential terms drop (t -* ">, exp(-kt) -* 0), and the steady state
room concentration can be described,
-   ro C. Q. + G
C (CFU/m ) =-------—---------- (Equation 1)
m(Q. + « Q^)
Assuming air mixes perfectly in the room (m = 1), the HEPA filter
removes all the fumgal spores from air passing through the filter (5 =
1), and the roof spore concentration (C.) remains constant:
-   C. Q. + G
C (CFU/m ) = ——^^---- . (Equation 2)
#•
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3
The room spore concentration would become 49 CFU/m , if typical values
3 3
are substituted for these variables:  C. = 175 CFU/m ; Q. = 530 m /hr;
3Q = 1377 m /hr: and G = 0 CFU/hr for no source of spores inside the
room.  This calculated value for conditions without AH-31 filtration is
3
65 times higher than the measured room average of 0.75 CFU/m .
The effect of removing the recirculating HEPA filter from the
patients* room can be calculated from the experimentally derived C. C.
Factors in Table 13 (page 24). The ratio of the patient room C. C.
Factor with HEPA filtration to that without HEPA filtration is
approximately five. This experimental result agrees with that predicted
from the above-mentioned, one-compartment model. Using the same
variable values. the ratio of the room concentration without
recirculating HEPA filtration to one with HEPA filtration is about four.
So HEPA      (S^i ^ G)/ Qi      % ^ %        530^^^7
SePA    (C.Q. + G)/(Q^ + Q^)     ^i 530
Based on the expected effect of removing one of the engineering
controls from the patient room, the following ranking can be formulated
based on the expected increases in patient room concentration:
AH-31        HEPA positive
filtration >> filtration > pressure
effect       effect barrier
( 65X )       ( 5X )        { 4X )
This analysis, of course, is based on specific hypothetical
conditions. If this analysis is repeated using postoccupancy baseline
averages for room and hall, the effect of removing the positive pressure
barrier would exceed the effect of removal of HEPA filtration.
k•
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4.14 Two Component Removal: The positive pressure air barrier would
Taiik as the least important eunong the engineering controls, if the roof
inlet and patient room air remained unfiltered. The room air, at steady-
state, would approach concentrations on the roof. The presence of the
positive pressure barrier would then prevent the "dirty" room air from
being diluted with less contaminated hall air. Therefore, if two
engineering control components are removed, the positive pressure
barrier would provide a negative contribution to cleanliness in the
patient room.
In hypothetical cases, when only one filter system is operating and
no positive pressure barrier exists, the bone marrow treinsplant unit as
a whole can be considered to be a single compartment. Single
compartment model variables can be expressed as sums or weighted
averages of airflow rates and concentrations supplied by the two air
handlers. After substituting values for conditions found on the
hospital unit in this study, the room concentration when AH-31 inlet
supply is unfiltered exceeds the room concentration when it is filtered.
Calculations are presented in Appendix F.
Based on the hjrpothetical conditions of removing two engineering
controls from the patient room, the following ranking can be formulated:
AH-31        HEPA        positive
filtration >  filtration >> pressure
effect       effect       barrier
( 6X )       ( IX )      (Negative)
This ranking agrees with the previous one-component rankings but the
separation between the rankings differ.
4.15  Environmental Factor Analysis:  Two directions were investigated
to associate patient room concentrations with environmental conditions.
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The first method consisted of ranking rooms by 'cleanliness' and
identifying environmental factors associated with either a low or high
level of cleanliness. The second method consisted of partitioning
sample results by levels of environmental factors. The resultant
contingency tables were examined to detect spore concentration
differences associated with the levels of the environmental variables.
Two simplifications were made to assist in these gmalyses. First,
the environmental factors were considered to be mutually independent.
Second, the number of fungi collected per sample was used as the
dependent variable, instead of the room spore concentration. Since the
period over which airborne spores were collected in the patient room
seldom deviated from 30 minutes, the voliome of air sampled cam be
considered a constant. This constant can be multiplied by the room
concentration to obtain the total number of fungi detected per sample.
4.16 Room Cleanliness Ranking: The average number of spores detected
and the percentage of sterile SEunples were investigated as measures by
which to rank room cleanliness. Since fungi were often undetected in
patient rooms, results were hypothesized to fit a Polsson model. If the
Poisson model fit, rooms could be judged more clean the lower the
Polsson parameter. If a criteria for cleanliness can be established,
environmental factors can be identified with levels of cleanliness.
The average number of spores detected were low and sample standard
deviations were high. Most standard errors exceeded the half of the
room average (see Table 16). No ranking could be Justified by average
number of spores detected because of the lack of separation between room
averages      and      the      large.      standard      errors.
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TABLE 16. PATIENT ROM RESULTS SUMMARY
Room Fvingi Detected Percent Sterile (n-l)s2
Xf,_i50.05)No. n
19
X ± s/y/K P ± TT X
1 0.53 ± 0.18 63 ± 11 20.4 9.4
2 12 0.08 ± 0.08 92 ± 8 11.0 4.6
3 12 0.83 ± 0.63 75 ± 13 63.4 4.6
4 12 1.00 ± 0.74 67 ± 14 72.0 4.6
5 17 0.29 ± 0.11 71 ± 11 12.0 8.0
6 12 0.50 ± 0.26 75 ± 13 17.5 4.6
7 11 0.55 ± 0.28 64 ± 15 16.0 3.9
8 4 0 ± 0 100 ± 0 - -
9 11 0.18 ± 0.18 91 ± 9 2.0 3.9
10 9 0 ± 0 100 ± 0 - -
11 5 6.40 ± 5.66 40 ± 22 100.2 0.7
12 13 0.62 ± 0.33 69 ± 13 27.8 4.6
13 10 0.10 ± 0.10 90 ± 9 9.0 5.2
14 9 0.56 ± 0.56 89 ± 11 40.0 2.7
15 4 0 ± 0 100 ± 0 - -
16 14 2.57 ± 1.77 64 ± 13 221.5 5.2
All
Rooms 174 0.787 ± 0.234 77.0 ± 3.2 2.160 210
A ± s/vTi = Average Number of Fungi Detected ± Standard Error
P ± ir = Percentage of Sterile Samples ± Standard Error
A ranking on the basis of percent of sterile samples would fail for
similar reasons. The percentage of sterile saunples for the 16 rooms
range from 40% to 100% (see Table 16). No fungi were found in three
rooms (100% sterile samples). For the other thirteen rooms, the
binomial model can be used to calculate the uncertainty in the
percentage of sterile samples, P. This uncertainty is estimated by ir,
where it = [(l-P)P/n] . When the uncertainty of the percentage of
sterile samples is considered, the data does not provide enough evidence
to support ranking the rooms in terms percentage sterile.
Two methods were used to examine the goodness of fit of a Poisson
model to the room results.  In the first, expected Poisson frequencies
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were calculated using each room average and compared to the study
2
results.  The goodness of fit test using the \     failed to accept the
model for all sixteen rooms.  In the second method (68). ratios of room
2
variances to room averages were compared to the suitable \     critical
value at 0.05 (See Table 16). The Poisson model was again rejected for
all but the results from one room (room 9). It is concluded from both
methods, that the patient room results, considered as replicates exhibit
too much variability to admit the Poisson model.
4.17_____Spore  Prediction by  B^^TU Variable:    Simple  predictive
relationships between the variables in Table 17 and patient room spore
concentration (respirable concentration spore concentration or total
spore concentration), number of spores detected, or spore generation
rate were examined on scatterplots. The spore generation rates were
calculated based on the one compartment model by rearranging Equation 2
(page 34):
G (CFU/hr) = C (Q. + Q ) - C. Q..
Measured values for room concentration (C) and flowrates for the inlet
supply and filter (Q. and Q ), along with postulated values for the
inlet spore concentration (C.) were used to calculate the hypothetical
source (or sink, when negative) strengths for spores to reconcile the
measured room concentration with the other room conditions.
No pattern was detected upon exeunination of the scatterplots, even
when transformations of the BMTU variables were performed (73).
Non-par£unetric analyses were performed to identify important variables
before other predictive models were fit (multiple regression or ANOVA).
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^ TABLE 17.  INDEPENDENT BJfTU VARIABLES
Date - d. from first sample day (4/2/88),
d. from BMTU opening (5/30/88);
Time - t. from earliest sample (7:42 am),
t. from noon (12:00 pm).
t. from 2 pm (2:00 pm);
Occupancy - number of room occupants;
Location - 1. of room from 9201,
1. from 9207;
Hall Concentration - respirable h.c,
non-respirable h.c,
total h.c.,
day's average h.c,
day's vicinity average h.c;
Contingency tables were assembled by counting sample results which
showed the presence of airborne CFU's in different catagories of
environmental variables. The chi-square statistic was computed and
compared to published values to detect differences in the levels of the
variable not likely to result by chance (49). Only one variable, the
number of persons in the room, resulted in a significant (p < 0.05)
chi-square statistic (see Figure 4).
Because only one variable was found to have a significant effect on
the presence or absence of fungi in the patient rooms, no computer
-intensive models were fit to the data.
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6
I Sterile Samples
Non-Sterile Samples
0       12
NUMBER OF ROOM OCCUPANTS
>2
Occupants
in Room
X3=31.0:
Sterile
Samples
P-value < 0.005
Non-Sterile
Samples
Row
Total
0
1
2
>2
79 (81%)
34 (92%)
16 (64%)
3 (21%)
19 (19%)
3 ( 8%)
9 (36%)
11 (79%)
98
37
25
14
Total 132 (76%) 42 (29%) 174
Percentage of row total given in parentheses.
FIGURE 4. INFLUENCE OF THE NUMBER OF OCCUPANTS IN THE PATIENT ROOM
ON THE DETECTION OF FUNGAL PARTICLES.
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5. DISCUSSION AND CONCLUSIONS
The previous section demonstrated that, like the death of the field
mouse, a number of factors can be associated with the presence of fungal
spores in patient rooms. Chief among these factors are the engineering
controls: air handler filters, recirculating HEPA filters, and positive
pressure air barriers.  The number of occupants was also associated with
the detection of spores within the patient rooms.  Infection control
policies protecting immunocompromised patients were formulated based on
these results.
The technique of paired, sieve samples used in this study was
successful in obtaining the following objectives.
1) The efficacy of the engineering controls was established.
Table 13 (page 24) demonstrates that the concentration of fungal
particles is reduced by the filters in the air handling units, and by
the recirculating HEPA filters in the patient rooms and the hallway.
Positive pressure in the BMTU produced an effective barrier in only two
of the ten airflows examined, as shown in Table 14 (page 26).
The relative effectiveness of the engineering controls is also seen
in the frequency plots presented in Appendix E. There is a distinct
separation between plots corresponding to the room amd the hall and the
room and the outside.  The success of the primary engineering objective
of a clean patient room is demonstrated by these separations.
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2) The method provided a basis for clinical risk assessment based
on BJCrU area cleanliness. Summaries are provided in sections 4.6
through 4.10 (pages 27-32). The patient room was found to be the most
spore free and therefore the safest.  Inside the hospital, the gowning
area was found to be the area most contaminated with fungal particles.
Furthermore, the appearance of potentially pathogenic spores was
associated with higher spore concentrations in the unit.
Although the unit was not found to be free of pathogenic spores,
the fungal particle concentrations were found to be low enough to allow
patients to be moved into the unit. Also. BMTU hallway concentrations
were found to be low enough to allow patients limited access to the
hallway.  Spore concentrations were expected to increase after patient
occupancy because of the concurrent increase in unit activity and
traffic from outside the unit.  On the contrary, the period after
occupancy showed a decrease in the patient room £md overall BMTU unit
averages (Table 15, page 28).  This may have resulted from fewer
disturbances due to BMTU construction and increased housekeeping during
the post-occupancy period.
3) The engineering design components were ranked in importance in
controlling fungal spores in the patient room.  By using experimental
data, hypothesizing engineering control failure, and applying a single
compartment model, the filters in the air handling units were found to
be the most important factor affecting spore removal.  The recirculating
HEPA filter in the room controlled fungal particles room better than the
positive pressure air barrier.  The positive pressure barrier was found
to be the least important component in maintaining low patient exposures
to fungal spores.  (See pages 32-36)
h*
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Because of the lack of experimental controls, hypothetical
conditions were postulated. The results agreed with theoretical
expectations. Also, the removal of either one or two engineering
controls resulted in the same engineering control ranking.
Although consistent, the present engineering control ranking has
limited applicability.  The discussion in sections 4.12 through 4.14
stressed the dependence of the ranking on temporary and somewhat
subjective conditions. Likewise, because the rankings depend on data
collected in this study, other locations with different climatic and
ecologic conditions may experience different fungal challenges. These
challenges will determine the relative importance of the engineering
control components.
4) One environmental factor was successfully associated with the
presence of fungal particles in the patient room. An increase in room
occupants increased the likelihood of detecting fungal particles. As
illustrated in Figure 4 (page 41), this result (p < 0.005) was obtained
by applying non-parametric methods of analysis.
Further discussion in this section will be limited to three areas:
BMTU air cleanliness and fungal infection (acceptability), limits of the
impactor sampling method for risk assessment (accuracy), and
recommendations for spore surveillance in the BMTU (evaluation). The
validity emd specific implications of each of the results presented in
the previous section will not be directly addressed.
5.1 BMTU Air Acceptability: No incidence of air-transmitted fungal
infections was detected during the study period.  It may be concluded
that the spore concentrations in the patient rooms were below harmful
levels, preventing at-risk patients from being infected by pathogenic
*#
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spores. The veracity of this assertion relies on accurate disease rates
and patient exposure estimates.
The detection of pulmonary fungal disease remains difficult (60,
88).  This is borne out by the fact that treatment based soley on
circumstantial evidence has been recommended by some investigators (1).
In the past, a substantial proportion of cases of opportunistic fungal
infection were detected post-mortem (12, 57).
Patient exposures may have been overestimated or underestimated in
this study. Air sampling occurred during daytime and hours of high unit
activity. Other investigators have demonstrated an association between
high activity levels and high spore concentrations.  Alternatively,
patient exposures may have been underestimated if sampling did not occur
during periodic episodes of high concentrations of fungal spores.
If future air sampling results are to be compared to the results of
this survey, a few precautions must be considered. Estimates of patient
exposure should be obtained by sampling techniques similar to the one
used here. Sampling method, location, and time should be matched.
Changes in patients' susceptibility (for example shorter or longer
periods of neutropenia) should also be taken into account. A further
difficulty arises from the fact that we do not yet have a suitable
statistical model (Poisson, normal or lognormal) for this data.  The
Bioaerosols Committee of the ACGIH recognizes that the results of
bioaerosol sampling rarely follow standard parametric distributions
(16). Lack of a suitable model make comparisons a more complex task.
A review of the literature reveals that few studies have associated
prospective volumetric seimpling with rates of opportunistic fungal
infection.  Of the reports in Table 3 (page 7), only one, at the
*•
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University of Minnesota (86,87), shows that Infection rates decreased
with a reduction in average spore concentration (as a result of
recirculating room HEPA filtration). \¥hen Aspergillus concentrations
3 3were reduced from 2.0 CFU/m to 0.9 CFU/m , the cases of aspergillosis
were reduced from 4 in 66 to 7 in 202 bone marrow transplant patients.
Rhame and associates provide a good discussion of this risk factor and
offer practical recommendations for the prevention of infection (86).
In the 1960's, medical applications of HEPA filtration begEin with
local isolation for surgery (64), followed by patient Isolation by a
commercial device supplying HEPA filtered air, to an inflatable plastic
tent (48).  These applications were quickly applied to patients
receiving chemotherapy for cancer (96).  Concurrently, the need for
skin, nose, throat, and gastrointestinal tract decontamination was
recognized (20). Rooms with a wall or ceiling supplying unidirectional
HEPA filtered air were developed (72) and evaluated with systemic or
nonabsorbable antibiotics to complete patient decontamination (19).
These total protected (gnotobiotic) environments and antibiotic
regimens have been shown to reduce (but not eliminate) the number of
airborne or colonizing microorganisms and reduce infection rates.
Demonstrated increases in remission rates and rates of patient survival
have been difficult to reproduce. Various Infection prevention
strategies were investigated during the last two decades.  Pizzo's
schematic representation of the rising and falling levels of the use of
infection prevention strategies is provided in Figure 5. As shown in
the figure, gnotobiotic environments are experiencing renewed interest.
Present applications include laminar airflow rooms for patients with
solid tumors, similar to those cancers experienced by patients on this
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BJrrU.  Pizzo and Levine present a good review of controlled environments
(83).
1965—^
Trimethoprim-
sulfamethoxcizole
Prophylaxis
Active
Immunization
Oral
Nonabsorbable
Colonization
Resistance
Total Protected
Environment
Prophylact
Leukocytes
Passive
•        Immunization
1980—1-------1-------1
FIGURE 5. TWO DEX:;ADES of INFEXTIOf PRYENTION STRATEGIES. (82)
The rising and falling of use reflect the ability
to confirm (or fail to confirm) a reproducible
benefit of a given regimen.
Criticism of ptatient isolation in gnotobiotic environments began in
the early 1970's (55) and reemerged a decade later (10, 81). Currently,
less expensive measures are being investigated and have been shown to be
efficacious (75). The cost of providing unidirectional laminar air flow
was a consideration in the design of this BtTTU.
5.2 Exposure Assessment Accuracv- As previously mentioned, the
two-stage sieve sampler employed in this survey collects the total
number of airborne particles carrying fungi, spores, or conidia.  For a
variety of reasons this collection method underestimates the total
k*
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number of fungal microorganisms (22).  The liquid impingement collection
method, however, reflects the total number of fungi suspended in the
air. Therefore, it is a more suitable method to estimate patient
exposure, if patient infectivity is based on the total number of viable
fungal orgEinisms. One such liquid impinger system, the AGI 30 operated
at 12.5 1pm, has been recommended as a standard method (21). The
attachment of a pre-impinger to the AGI allows for added aerosol size
discrimination (71).
If the size distribution of the CPUs (or the infection site, i.e.,
nares us. lung) is a more important consideration then the total number
of organisms, the six-stage Andersen sieve sampler is the recommended
standard method (21).  Other investigators have found that the two-stage
sieve sampler produced lower values for airborne bacteria (30) and
Aspergtllus fumigatus  (40) than the Andersen sampler.  A. funigatus
collection efficiencies may be difficult to predict because of changes
in median spore size (77).  If the two-stage sieve sampler is used in
future spore collections on the BMTU, it is recommended that a membrane
filter be inserted behind the second stage and placed on agar after
sampling, to detect spore breakthrough.
Additional comments concerning each sampling method follow.
Sampling by either of these sieve samplers can be extended with the
application of a thin wax film on the agar to prevent dehydration (70).
A liquid impinger will require more careful handling, more time to
manipulate the sample, and careful selection of the impingement liquid.
The impinger liquid will require a surfactant to disperse hydrophobic
spores.  Whatever method is used to collect spores, field blanks should
be collected routinely to monitor contamination.
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Unlike the methods above. Impaction devices like the Fort Detrich
Slit Sampler. Fort Detrich Slit-Incubator Seunpler, and the Casella Slit
Sampler, give time-concentration relationships (113).  These devices can
detect transient increases in spore concentration. Besides providing
exposure data, they can assist in the identification of factors
contributing to these transient increases.
5.3 BMTU Surveillance: A complete program of infection control will
include environmental surveillsmce. Surveillance goals for specialized
patient care areas of a hospital are presented in the following
hierarchy:  detection of engineering control failure or building
construction; BMTU air quality monitoring; and neutropenic patient
exposure monitoring. Each of these objectives will be discussed
separately.
Reported outbreaks of fungal diseases were listed in Table 3 (page
7).  The causes contributing to these outbreaks provide a convincing
argument for detecting engineering control failures and building
construction. Checklists make surveillance relatively easy to
implement. Corrective measures are vinambiguous. This strategy of
surveillance assumes that the BMTU is otherwise acceptable.  It also
assumes that the failure of engineering controls or building
construction activity are the most important environmental determinants
of risk of air-treinsmitted fungal disease.
Proper monitoring of BMTU air quality can not only detect the
results of engineering control failure and building construction
activity, but also identify other factors influencing BMTU air quality.
Air quality monitoring may require more labor eind instrumental analysis.
An accurate historical basis for comparisons is necessary to identify
^#
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changes in air quality.  Data may accumulate at a relatively slow rate
and a detected change in air quality may be due to the interaction of
many factors.  This strategy of surveillance requires a long term
commitment, recognizing that implementable recommendations to improve
air quality will follow slow processes of data collection and analysis.
Patient exposure estimates extract the important information about
BMTU air quality into measurements immediately affecting patient dose.
Infection control efforts should be concentrated on limiting patients'
dose until effective methods of antibiotic prophylaxis exist.
Regrettably, patient exposure estimates are the most invasive, the most
difficult to conduct, and the hardest to interpret.  Again,
multicausality makes it difficult to prescribe effective corrective
measures to reduce patients* exposures.
The focus of environmental measurements should obviously support
goals of infection control surveillEince. A hierarchy of measurement
objectives which could support a BMTU surveillance program, are
presented in Table 18. The phenomena appearing down the list become
more difficult to measure. They also become more applicable toward
judgements of infective risk. Airborne measurement objectives in this
table are nested. That is, any airborne objective listed, contains all
contaminants lower in the table. Advantages and disadvantages for each
of these environmental measurement objectives will be discussed below.
TABLE 18. POSSIBLE OBJECTS OF EKVIRCOTIENTAL MEASUREMENT
Settled or trapped fungal spores
Airborne particulates (total, nonspecific)
Airborne spores (viable and non-viable)
Viable airborne fungal organisms
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Settled or trapped fungal spores are the easiest to collect.
Included in these types of measurements are: air-cleaning filter
sampling, wipe sampling, and gravity-settle plate collection methods.  A
reproducible method of recovery of spores from air cleaning filters must
overcome difficulties of spore viability and efficiency of capture.
Since roughing filters in the BMTU room HEPAs are replaced after each
jjatient, analysis could provide qualitative information on the patient's
most recent exposures. Wipe sampling and settle plate methods have poor
efficiencies for smaller spores, like the conidia of Aspergillus
species.  These methods may be more applicable when fungal particles
originate from attrition processes, like hospital construction.  Despite
the difficulties in interpretation, collection methods for settled or
trapped spores are among the methods most often used.
Volumetric air measurements are more directly applicable to
estimating patient exposure than the collection of non-airborne fungi.
Recommendations for instrument and method selection of continuous,
instantaneous, or time-integrative techniques, are available for
airborne particulates (5), spores (78), and viable organisms (113).
Ultimately, we are concerned with the number of viable pathogenic fungal
organisms which may be inhaled by the neutropenic or otherwise,
compromised patients. We could substitute measurement objectives and
infer patient dose, if individual pathogens comprised a predictable
portion of airborne fungal particles, spores (viable and non-viable), or
total particulates.  Presently, there is no evidence to suggest that
this is so.
Currently, genus and species of many spores of the Deuteromycetes
class cannot be identified except by culturing. Often the spores
4•
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themselves cannot be distinguished from inorganic particulates.  In
addition, spore viability cannot be determined except by culturing.
A successful program of infection control in the BMTU requires the
involvement of the patient, medical staff, engineering and maintenance
department, houskeeping personnel, and the infection control department.
The various groups should participate in the selection of surveillance
goals.  Cooperation of all those concerned will greatly enhance
environmental data collection and other activities focused toward
environmental control.
4•
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6.  FURTHER RESEARCH
In this study, fungal particles were measured in a specialized
patient care area of a hospital. A number of factors were successfully
shown to influence the presence of potentially infectious agents in the
patient room.  As the objectives of this study were met, the need for
further investigation became apparent. Given the current limits of
time, money and instrumentation, a strategy for further research is
outlined below. The following plan emphasizes the accurate estimation
of patient exposure to fungal organisms.
Additionally, this research would enable us to accomplish important
goals.  It would characterize the aerodynamics of the patient room,
validating or invalidating the substitution of area sampling for
breathing-zone sampling.  It would identify and characterize variables
to predict the room fungal spore concentration using a mass-balance
model.  And this strategy may identify the relationship between the
concentration of airborne fungal organisms and other suspended
particulates to simplify the analysis of air seunpling.
Rooms like those in this BMTU have been shown to be less effective
in controlling airborne microorganisms than unidirectional laminar air
flow rooms (9). However, if patient exposures in rooms of this BMTU are
found to be below infective levels, the expense of providing expensive
unidirectional laminar airflow can be avoided.
4^
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6.1 Room Aerodynamics: The patient rooms have a relatively simple
configuration.  After careful measurements of room volume, room air
supply, exhaust, etc., airflow can be characterized by velocity
measurements at points in a three dimensional grid. A circuit of air is
expected to pass through the HEPA filter unit to the patients' breathing
zone and return to the HEPA filter. Measurements can be made to observe
airflow pattern changes which result from different rates of HEPA
filtration.  If similar airflow patterns are achievable by replacing the
HEPA filters with a simple diffuser, the effect of HEPA filtration cein
be quantified.
Using a suitable tracer gas and  instrument which continuously
records concentration of the gas, the mixing of the air in the room suid
decay rate of the tracer gas can be observed. Results should agree with
concentrations based on a one-compartment model. Concentration
measurements should be made in the patients' breathing zone and compared
to other sampling areas in the room. To simulate possible contaminant
sources, the tracer gas should be releases from areas near the air
supply and all exhaust locations. The rate of HEPA recirculation should
be varied in experimental trials. At this point, conclusions can be
made as to whether area air sampling can be representative of breathing
zone values for a gaseous contaminant.
After the behavior of the tracer gas is adequately characterized,
the experiments should be repeated with a suitable aerosol tracer.
Potassium iodide (36.37) and sodium chloride (38) particles have been
successfully used as experimental tracers in a hospital setting.
Previous studies have found aerosols transfer less effectively than
gases (47). Observations of the aerosol decay rate and mixing behavior
^ii
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of the room based on aerosol measurements are expected to be similar to
gas values when a simple diffuser is substituted for the HEPA filter.
Again, the aerosol measurements should stress the patient's breathing
zone suid the source of the aerosol generation should be near the air
supply inlet, the ceiling exhaust, and undercuts of the bath, toilet and
hall doors.  When the HEPA filter is returned to the filter unit,
measurements should agree with decay rates resulting from 100%
filtration.
At this time, it can be determined whether area particulate
sampling can be substituted for breathing zone sampling.  If the
substitution cannot be made, recommendations for locations of air
sEimpling on the BMTU should reflect this fact. Otherwise,
recommendations toward a single sampling location, producing results
which represent the aerosol concentration in the room, can be made at
this time.
6.2 Predictive Model:  Results from air samples in the BMTU may be used
to estimate patient breathing zone exposures.  The AGI 30 or an
equivalent method should be used. The AGI 30 method accurately measures
the number of airborne fungal organisms.
If comparable results are obtained by using some other air quality
measuring technique, it could be substituted for the AGI 30. The liquid
Impinger method is time-lntegrative.  If the alternate method provides
continuous monitoring, we may be able to detect instantaneous changes in
air quality more accurately.
A thorough record of important variables influencing (or thought
to influence) fungal spore concentration should be kept.  Room and inlet
spore concentrations should be measured. Spore concentrations outside
h•
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the room door should also be measured, as well as, frequency and speed
of door opening.  This can be accomplished by a rheostat connected to
the door hinge. A strip chart recorder can be used to record the
position of the door at any time.
One study (111) using a gaseous tracer, found that the amount of
air transferred by opening a 3 ft x 7 ft door,  was half a cubic meter.
The result was shown to be independent of the temperature gradient
between hall and room, for a six-second door opening.  In another
experiment, particularly well designed. Keimig and associates (56)
showed that the velocity of door opening affected the transfer of
airborne contaminants in a scale model. The same study showed that the
present direction of door swing on the BMTU is more prone to transfering
contaminants from the hall to the room.
Ultimately, the data collected should be assembled in the form of a
mass balance equation (Equation 1, page 34), so that the validity of the
model can be experimentally tested.  Different factors influencing air
quality may be identified by each method. When the methods agree,
inferences may be made concerning the relationship between the different
objects of measurement. Statistical methods of time series and
autocorrelation may be used to euialyze continuous data.
6.3 Surrogate Sampling:  If a method of air quality monitoring produces
comparable results to our standard method, it can be substituted to
reduce analysis time, effort and expense.  It should be clear, after
enough data has been collected to test the one-compartment model,
whether the alternate method selected is an adequate substitute for the
AGI.  If it is not clear, the comparison may resume. Otherwise,  a
different technique of air quality measurement may be selected and
57
4 compared to the AGI.  Meanwhile, patient exposures are regularlyestimated and, hopefully, additional factors influencing air quality
recognized.
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Ji SAMPLING PROCEDURE
Materials
Pen and paper for recording sampling conditions
Vacuum pumps and 2-stage Andersen Impactors
, Alcohol wipes and garbage bags
100 mm Sabouroud Agar Plates
Measuring tape and stopwatch
BMTU map and smoke tube with bulb
Ziplock Bags to secure exposed agar plates
Procedure
1. Record sampling conditions. Try to pair samples across control
measures or barriers.  i.e. across a closed door.  Record DATE,
TIME, SAMPLE DURATION, LOCATION (record on BMTU map), HEIGHT.
SAMPLE TYPE (if not impactor, i.e. wipe), HEPA ON?. NUMBER OF ROOM
OCCUPANTS, HALL DOOR OPEN?. VENTILATION ON?. COLLECTION OPERATOR,
etc. Use NOC to specify Normal Operating Conditions.
2. Prepare 2-stage Andersen impactor by wiping above and below agar
plate with an alcohol wipe prep pad.  A finger inserted at the
fold will allow two surfaces surrounding the sieve to be wiped
with one sweep.
3. Assemble impactor with agar plates, verifying the plate is labeled
correctly and is gently rocked into its correct position on the
bottom of each stage.  Place plate lids face down so no spores
settle on lid while seimpling.
4. Plug in vacuum pumps recording the time. Sample for 30 minutes.
Record sample duration to the nearest one-half minute.
5. While sampling, smoke test rooms which communicate with the BMTU
hallways, as well as the exits, gowning area, and workroom.
Record results on BMTU map.  If the smoke test indicates the air
is flowing from the hall into the patient room, inform the Head
Nurse, Michael Plumer.
6. After unplugging vacuum pumps, disassemble the impactor noting if
the plates are correctly labeled.
o
7. Incubate plates at 30 C in the Clinical Microbiology Laboratory,
agar side up. in the plastic Ziploc Bags.
8. After three days, record the number of colonies on each plate,
identifying numbers of recognizable fungi.  Confirm the presence
of Aspergillus spp. or other potential pathogens with Medical
Mycology.
^APPENDIX C
#
4i»
AGAR PLATE PREPARATION.
Materials
Dextrose,  20g
Popypeptone,  lOg
Agar,  20g
Distilled Water,  1000ml
Procedure
Mix thoroughly emd heat with frequent agitation. Boil for
approximately one minute until a solution occurs. Sterilize for 15
minutes at 121 C at 12-15 psi and allow to cool to 56 C. Dispense
18ml into 100 X 15 mm petri dishes using Pourmatic.  When cool,
label dish 'SAB' emd heat seal in plastic sleeve. Refrigerate and
o
store in walk-in cooler at 40 F
^APPENDIX D
b
ample   Dur ation Occupancy Analysis F'esults Fungus Ccnc.
No. Date <min) Location No. HEPA lat Stage 2nd Stage <c£u/m3>
1 380425 30 9211 Hall MA NA NA lUn 1.23
2 380425 30 9211 Room 0 no NA 26Pe3Un 35.56
3 880425 30 9203 Hall HA HA 2Un lUn 3.63
4 330425 30 9203 Roon 0 yea HA MA O.OO
5 880506 30 9216 Room 0 no NA 1C1 1.23
6 830506 30 9216 Hall NA NA ' NA NA 0.00
7 830506 30 9213 Hall NA NA NA 3Pe 3.63
S 280506 20 S3X3 Room O yes NA MA 0.00
9 830506 30 9204 Hall NA NA NA 5Pa 6.13
10 330506 20 9204 Rooa 0 yes NA IPe 1.23
11 380510 30 9201 Hall NA NA HA MA O.OO
12 880510 20 9201 Room O yes NA NA 0.00
13 830510 30 9220 Y NA NA NA 1AF 1.23
14 330510 30 9200 Y NA NA NA NA 0.00
15 380511 30 9203 Hall NA NA MA MA 0.00
16 830511 30 9203 Room 0 yea NA MA 0.00
17 380511 20 9207 Hall NA NA NA MA 0.00
13 330511 30 9207 Room 0 yes NA MA 0.00
19 880512 30 9202 Hall NA NA 2Un MA 2.45
20 330512 20 9202 Room 0 yes MA MA 0.00
21 330512 20 9206 Hall NA NA MA MA 0.00
22 380512 20 9206 Room 0 yes NA MA 0.00
23 330512 20 9205 Hall NA NA 2yn lUn 3.68
24 880512 20 9205 Room 0 yes lUn NA 1.23
25 330512 20 9204 Hall NA NA NA 2Un 2.45
26 2SC513 20 9204 Room 0 yes MA MA 0.00
27 330516 30 9213 Room o yea NA NA 0.00
23 330516 20 Q^-f O Hall NA NA NA MA 0.00
29 330516 30 9216 Room 0 no NA NA O.OO
20 330516 30 9216 Hall NA NA MA .NA 0.00
31 330516 34.5 9209 Room 0 yes MA NA 0.00
32 330516 34 9209 Hall NA NA 2HS NA 2.16
33 SS0516 20 9205 Hall NA NA NA NA 0.00
34 330515 30 9205 Rooa 0 yes 1C1 NA 1.22
35 380516 20 9201 Hall NA NA 2HS NA 2.45
36 330515 30 9201 Room 0 yes NA NA 0.00
37 330520 30 9201 Room O yes NA NA 0.00
33 330520 30 9201 Hall NA NA lUr. 3Un 4.90
39 330520 30 9100 Y NA NA 5Un 7Un 14.71
40 330520 30 9205 Rooa 0 yes NA NA 0.00
41 330520 30 9205 Hall NA NA lUn NA 1.23
42 330520 31 9209 Rooa 0 yes MA MA 0.00
43 320520 30 9209 Hall MA NA MA 2Un 2.45
44 330520 20 9212 Room 0 yes MA HA 0.00
45 330520 30 9213 Hall NA NA MA 2Un 2.45
46 330520 30 9216 Room O no lUn 24Un 30.66
47 330520 31 9216 Hall NA NA 4Un HUn 17.30
43 380520 31 9300 Y NA MA 4Un 4Un 9.49
49 330520 30 9200 Entry NA NA MA 4Un 4.90
Sanple   Duration       Occupancy   Analysis Results
No. Date   (nin) Location   No. HEPA 1st Stage  2nd Stage
Fungus Cone.
Ccfu/ni3)
50
51
52
53
54
55
5S
57
53
59
81
82
33
34
85
as
87
83
39
90
91
92
93
94
95
96
97
93
99
100
101
102
103
104
105
106
107
103
111
112
113
114
115
116
117
113
119
120
121
830520
380520
330525
330S2S
330525
88052S
230525
880525
330525
330525
380530
830520
330530
330530
380520
330530
880530
330530
330531
330531
330531
330531
S30eol
330531
830531
330531
330531
830531
380601
880601
830601
330501
330601
330601
330601
330601
330601
380601
380603
330603
330602
330603
330603
830603
880603
330603
330603
330603
830606
30
30.5
30
30
30.5
SO
30
30
31
31
30
30
30
20
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
31
31
30
30
30
30
20
30
30
30
30
30
30
30
30
30
30
30
30
9200
9220
9216
9216
9209
9209
9201
9201
9205
9205
9205
9205
9201
9201
9209
9209
9200
9220
9216
9216
9213
9213
9209
9209
9201
9201
9205
9205
9201
9201
9205
9205
9209
9209
9213
9213
9216
9216
9216
9216
9201
9201
9213
9213
9209
9209
9205
9205
9201
Y
Y
Room
Hall
Room
Hall
Roosx
Hall
Room
Hall
Hall
Room
Hall
Room
Room
Hall
Y
Y
Room
Hall
Room
Hall
Room
Hall
Room
Hall
Room
Hall
Room
Hall
Room
Hall
Room
Hall
Room
Hall
Room
Hall
Room
Hall
Room
Hall
Room
Hall
Room
Hall
Room
Hall
Room
NA NA
NA NA
O no
NA NA
0 yes
NA NA
O yes
NA NA
0 yes
NA NA
NA NA
0 yes
NA NA
0
0
yes
yes
NA NA
NA NA
MA NA
0 no
NA NA
0 yes
NA NA
0 yea
NA NA
0 yes
NA NA
1 yes
NA NA
1 yes
NA NA
2 yes
NA NA
0 yes
NA NA
0 yes
NA NA
0 no
NA NA
0 no
NA NA
2 yes
NA MA
0 yes
NA MA
0 yes
NA NA
1 yes
NA NA
1 yes
2Un
lUn
NA
lUn
NA
1C11HS
NA
1HS
MA
NA
NA
MA
NA
NA
NA
NA
?Pe?HS
?Pe?Un
MA
lUn
NA
NA
MA
lUn
NA
3Un
NA
NA
MA
lUn
MA
NA
MA
2Un
NA
2Un
NA
NA
3Un
NA
lUn
3Un
HA
lUn
NA
lUn
NA
NA
MA
4Un
NA
NA
2C1
2C1
2Pe2HS
ICHPa
3C14Pe
NA
4Un
NA
NA
MA
NA
NA
1HS
?Pe?Cl?HS
?PelAT
NA
13UnlAFlAB
NA
4Pe
NA
NA
NA
lUn
NA
3Un
NA
2Un
NA
2Un
NA
6UnlAB
lUn
14Un
NA
lABlAB22Un
lUn
2Un
NA
MA
NA
lUn
NA
2Un
NA
2Pe
NA
7.36
1.21
0.00
3.63
•2.41
7.36
2.45
9.81
0.00
4.75
0.00
0.00
0.00
0.00
O.OO
1.23
22.07
46.60
0.00
19.62
0.00
4.90
0.00
1.23
0.00
4.90
0.00
3.63
0.00
3.63
0.00
2.37
0.00
11.04
1.23
19.62
0.00
29.43
4.90
2.45
1.23
3.63
0.00
2.45
0.00
3.68
0.00
2.45
0.00
Sampla   Duration        Occupancy    Analysis Results      Fungus Cone
No. Data   (min) Location   No. HEPA Ist Stage  2nd Stage      (cfu/m3)
122 330606 30 9201 Hall NA NA 5Un
123 SS0606 33 9205 Room 2 yes NA
124 330606 33 9205 Hall NA NA NA
125 SS0506 29.5 9209 Room 0 yes NA
126 380606 30 9209 Hall NA NA NA
127 3SCSOS 30 9213 Room O yes NA
123 330S06 30 9213 Hall NA MA lUn
129 330505 30 9216 Room 0 no lUn
130 3S0606 30 9215 Hall NA NA ICl
131 330603 30 9201 Room 2 yes I'Jn
132 330503 30 9201 Hall NA NA lUn
133 380603 30 9205 Room 1 yes lUn
134 330603 30 9205 Kali NA MA MA
125 330603 30.5 9209 Room 0 yes NA
136 330603 30 9209 Hall MA MA lUn
137 330503 30 9213 Room 0 yes NA
133 330603 30 9213 Hall NA NA lUn
139 330503 30 9216 Room 0 no MA
140 SSC60S 30 9216 Hall MA NA 2!Jn
141 330509 30 9202 Room 1 yes MA
142 330609 30 9202 Hall NA NA 2Un
143 380609 30 9204 Room 2 yes lUn
144 330609 30 9204 Hall NA NA 3Un
145 330509 30 9205 Rccnx ͣ-> yes I'Jn
146 330509 30 9206 Hall NA NA NA
147 330609 30 9200 V NA NA lUn
143 33C609 30 9220 Y NA NA lUn
149 33C609 30 9203 Room 0 yes NA
150 330609 30 9203 Hall NA MA MA
151 330510 30 9201 Room 1 yes lUn
152 330610 30 9201 Hall MA NA MA
153 330510 29.5 9203 Room 1 yes MA
154 330510 2o ^ 5 9203 Hall NA NA NA
155 330610 30 9207 Room 5 yes 3Un
156 330610 30 9207 Hail MA MA NA
157 330610 30.5 9210 Room 1 yes MA
153 330510 30.5 9210 Hall NA NA NA
159 330610 30 9215 Room 0 no NA
160 330610 30 9216 Hall NA NA NA
161 330512 30 9200 Y NA MA IRh
162 330513 30 9220 Y MA MA 7Ur.
163 330613 30 O^Q 1 Room 4 yes MA
164 330613 30 9201 Hall NA NA lUn
165 330613 30 9204 Room r> yes MA
166 330613 30 9204 Hall NA NA NA
167 330613 30 9206 Room 1 yes NA
163 330513 30 9206 Hall NA NA 1H£
163 3S0613 30 9203 Room 0 yes NA
170 330613 30 9203 Hall NA MA 2Un
5Un
ICl
lUn
NA
6Un
NA
3UnlAFlPa
3Un
lAFlABlAB14Un
NA
lUn
NA
MA
NA
2Un
NA
lAb6Ab3Abl7Un
NA
lAb3At6Un
NA
- Vn
NA
20'n
NA
MA
MA
3Un
NA
MA
1AM
MA
NA
NA
MA
lUn
NA
lUn
NA
IZy
IRh
lRh2Un
IPe
NA
NA
NA
NA
NA
NA
ICl
12.25
1.11
1.11
O.OO
7.36
O.OO
13.49
4.90
22.07
1.23
2.45
1.23
0.00
0.00
3.68
0.00
34.33
0.00
14.71
00
63
23
13
0.00
1.23
,90
,00
,00
,45
,00
0
1
->
12
i
1
0
0.00
0.00
3.63
1.23
0.00
1.21
00
23
45
26
23
23
00
0.00
0.00
1 .23
0.00
3.58
Sample        Duration Occupancy Analysis' R-asults
Mo.   Data        (min)   Location        No.   HEPA   lat   Stage     2nci   Stage
171 330613 30 9211 Room O yes NA IPe
172 330613 30 9211 Hall MA NA 2Un NA
175 330614 30 9214 Room 0 no NA NA
176 330614 30 9214 Hall MA NA NA 2Un
177 330614 30 9207 Room 0 yes NA NA
173 3SOS14 30 9207 Hall MA NA 2rjn lUn
179 3S0£,14 30 9210 Room 1 y23 NA NA
130 330614 30 9210 Hall MA NA 2'Jn lUn
131 33C614 30.5 9212 Room 0 no NA NA
132 330614 30.5 9212 Hall MA NA NA lUn
132 330614 30 9202 Room 3 yes NA NA
134 330614 30 9202 Hall MA NA IAN NA
1 0<5 330514 30 9203 Room 1 yes NA NA
136 330614 30 9203 Hail HA NA lUn ICl
137 230615 30.5 9202 Room --> yes NA lUn
133 330615 30 .5 9202 Hall MA NA NA 3C1
139 330615 30 9204 Room o yes NA ICl
190 330615 30 9204 Hall MA NA 2Un 2CllUn
191 330615 20 9206 Room 2 yes NA NA
192 330615 30 9206 Hail NA NA t TT« I'Jn
193 330615 30 9200 Y NA NA 4Un 3Un
194 330615 30 9220 Y NA NA 4UnlGl 4Un
19= 330615 30 9203 Room 0 yes NA NA
196 330615 30 9203 Hall NA NA lUn NA
197 330615 30 9215 Room 0 yes NA NA
193 330615 30 9215 Hall NA NA lUn lUnlCl
199 330616 30 9203 Room 3 yes 4Un 4C1
200 330616 30 9203 Hall NA NA 3Un lUn
201 330616 20 9207 Room 1 yes NA NA
202 830615 30 9207 Hall MA NA lUn IAN
203 330616 30 9210 Room 1 yes NA NA
204 330616 30 9210 Hail NA NA lUn 2'JnlCl
205 330616 30 9200 Y NA NA lAF3Un 5Un
206 330616 30 9220 Y NA NA 12HS4UnlCl 3Un3Cl
207 330616 30 9212 Room 0 no NA NA
203 330615 30 goi^--> Hail NA NA lUn NA
209 330516 30 9215 Room 0 yes NA NA
210 330616 30 9215 Hall NA NA 2Un 4Pe4Un
211 330617 30 9214 Room 0 no NA NA
^1 --> 330617 30 9214 Hall NA NA NA NA
•-.->•-> 330617 30 9202 Rcom •-> yes MA NA
214 330617 30 9202 Kail NA NA lUn NA
215 330617 30 9211 Room 0 yes NA NA
216 330617 30 9211 Hall NA NA NA NA
217 330517 30 9204 Room 2 yes NA NA
213 330617 30 9204 Hail NA NA 2Un 2Un
219 330617 30.5 9206 Room O yes NA NA
220 330617 30.5 9205 Hall NA NA lUn NA
->^ t S3CS17 30 9203 Room O yes NA NA
Fungus 2onc
(c£u /m3)
1 .23
o .45
0 .00
2 .45
0.00
ͣr> .63
0 .00
3 .53
0 .00
1 .21
0 .00
1 . 23
0 .00
2 .45
1 .21
3 .52
1 .23
5 1 o
0 .00
-> .45
3 .53
11 .04
0 .00
1 . 23
0 .00
3 .53
9 .31
4 .90
0 .00
2 45
0 .00
4 90
11 04
23 20
0 00
1 23
0 00
12 26
0 00
0 00
0 00
1. 23
0. 00
0. 00
0. 00
4. 90
0. 00
1. 21
0. CO
Sample   Duration       Occupancy   Analysis Reaulta
No. Date   (min) Location   No. HEPA lat Stage  2nd Stage
Fungus Cone.
(c£u/ni3>
'>24
225
226
22S
223
230
231
'>32
233
234
237
223
240
241
ͣ^42
'>43
244
245
24S
247
248
249
250
251
252
253
254
255
25S
257
259
2S0
261
262
263
254
255
255
267
263
259
270
271
272
S30S17
830620
330620
830620
880520
800S20
330620
880520
880620
830620
380520
330520
380520
380523
330522
380522
330622
380522
330522
880522
330622
330622
380522
880522
330527
330527
330627
830627
880627
330627
330527
380627
380704
330704
880704
380704
830704
830704
330704
330704
330704
380704
830704
830704
880704
330704
SS070S
830703
20
20
30
20
30
30
30
34
34
20
30
20
30
20
30
20
30
20
30
30.5
30.5
30
30
20
20
30.5
30.5
30
30
30
30
30
30
30.5
30.5
30
30
30
30
30
30
30
20
30
30
30
30
20
20
9208
9202
9202
9204
9204
920S
920S
9200
9220
9210
9210
9215
9215
9201
9201
9202
9203
9205
9205
9207
9207
9211
9211
9215
9214
9214
9212
9212
9222
9209
9209
922°
9201
9201
9203
9202
9205
9205
9207
9207
9204
9220
9200
9220
9202
9206
9201
9201
Hall
Room
Hall
Room
Hall
Room
Hall
Y
Y
Room
Hall
Room
Hall
Room
Hall
Room
Hall
Room
Hall
Room
Hall
Room
Hall
Room
Hall
Room
Hall
Room
Hall
Room
Room
Hall
Stair
Room
Hall
Room
Hall
Room
Hall
Room
Hall
Room
X
Y
Y
Room
Room
Room
Hall
NA MA
2 yes
MA MA
2 yes
MA MA
0 yes
MA MA
MA MA
MA MA
1 yes
MA MA
0
MA
1
no
MA
yes
MA MA
0 yes
MA MA
1 yes
MA
1
MA
0
MA
yes
MA
yes
MA MA
0 yes
MA MA
0 no
MA MA
0 no
MA MA
MA MA
0 yes
MA MA
NA MA
1
MA
2
yea
MA
yes
MA MA
3 yes
MA NA
2 yea
MA NA
1 yes
NA MA
NA NA
NA MA
0 yes
3
1
yes
yes
MA MA
NA
NA
2Un
7Un
NA
NA
3Un
9Un
12Un
MA
lUn
lUn
I'Jn
NA
3Un2Cl
MA
3Un3Cl
MA
lUn
MA
3Un
MA
2Un
MA
lUn
NA
NA
MA
MA
NA
NA
NA
2Un
NA
MA
NA
MA
NA
lUn
NA
MA
MA
lUn
3Un
32Un
NA
2Un
NA
MA
NA
MA
2Un
lUnlCl
NA
NA
lUn2Cl
25Un
21Un
NA
1AF
lUn
lUn
MA
2UnlCl
NA
2Un
NA
4Ci
MA
lAMlUnlCl
2Un
2C12Un
HA
NA
NA
lUn
NA
NA
NA
NA
NA
3UnlCl
NA
MA
NA
MA
1C1
I'Jn
MA
MA
MA
MA
3Un
5Un
MA
MA
NA
lUnlCl
0.00
0.00
4.90
11.04
0.00
O.OO
7.35
36.79
35.70
0.00
2.45
2.45
2.45
0.00
9.31
0.00
9.81
0.00
6.13
0.00
7.24
2.45
7.35
0.00
1.23
0.00
1.21
0.00
0.00
0.00
0.00
0.00
7.36
0.00
0.00
0.00
0.00'
1.23
2.45
0.00
0.00
0.00
1.23
7.35
45.37
0.00
2.45
O.OO
2.45
Sampla   Duration        Occupancy    Analysis Results
No. Data   <inin) Location   No. HEPA lat Stage  2nd Stage
Fungus Cone.
<cfu/ra3)
'^t' 3S0703
274 S30703
275 380703
276 SS0703
277 3S070S
^7*^ 3S0703
279 320703
230 330703
231 330703
232 3S070S
233 330703
234 3S0703
"^35 230715
226 320715
227 320715
228 820715
239 330715
290 330715
2'"^1 330715
2*^2 330715
293 320715
294 330715
295 320715
296 230715
297 330715
298 330715
OQQ 230'^''9
300 330719
301 330719
302 330719
303 320719
304 330719
305 330719
306 220719
307 330725
308 330725
309 330725
310 330725
311 320725
312 330725
oi*^ *^207'^'~
314 330725
315 230726
316 330726
317 880726
318 830726
319 330726
320 330726
321 330726
30 9203 Room 3 yes NA lUn
30 9203 Hall NA NA NA NA
30 9205 Room o yes NA HA
30 9205 Hall NA NA NA NA
32 9207 Room 5 yes NA ICl
32 9207 Hall NA NA lUn NA
30 9210 Room 1 yes NA NA
30 9210 Hall NA NA NA NA
30 9204 Room 1 yes NA NA
30 9220 X NA NA lUn NA
30.5 9202 Room 2 yes NA NA
30 9206 Room 1 yes NA NA
30 9201 Room 0 yes NA NA
30 9201 Hall NA NA NA lUnlCl
30 9203 Room 1 yes NA NA
30 9203 Hall NA NA 2C1 lUn
30 9205 Room 2 yes NA NA
30 9205 Hail NA NA 2Un lUn
32 9207 Room 3 yes NA lUr.
32 9207 Hall NA NA 7Un llUnlHS
32.5 9210 Room 1 yes NA NA
32.5 9210 Hall NA NA NA lUn
30 9202 Room ^ yes NA NA
30 9206 Room o yes NA NA
30 9204 Room 1 yes NA NA
30 9220 X NA NA lAB2Un 3Un
30 9216 Room 0 no NA NA
30 9216 Hall NA NA NA 25UnlAs
30 9213 Room 0 yes NA NA
30 9213 Hall NA NA NA lUn
30 9209 Room 0 yes NA NA
30 9209 Hall NA NA NA 2Un
30 9200 Y NA NA lOUn 3Un
30 9220 Y NA NA NA 12Un
30 9207 Room 1 yes NA NA
30 9207 Hall NA NA 2Un NA
31 9201 Room 0 yes NA NA
31 9201 Hall MA NA SUn 2As
30 9203 Room 3 yes NA IPa
30 9203 Hall MA NA NA NA
30 9205 Room ͣ-> yes NA NA
30 9205 Hall NA NA NA IAN
30 9220 Y NA NA 5Un SUn
30 9200 Y NA NA 3'Jn NA
30 9210 Room 1 yes NA NA
30 9210 Hall NA NA lUn lUn
30 9206 Room o yes NA NA
30 9206 Hail NA NA lUn NA
31 9202 Room 2 yss NA NA
1.23
0.00
o.co
0.00
1.15
1.15
0.00
0.00
0.
1,
0.
0,
0,
.00
23
.00
.00
.00
2.45
0.00
3.63
0.00
3.63
1.15
21.34
00
13
00
0.00
0.00
7.35
0.00
31.33
0.00
1.23
0.00
2.45
15.94
14.71
0.00
2.45
0.00
9.49
1 .23
0.00
0.00
1.23
9.31
3.63
0.00
2.45
0.00
1 • '^^
0.00
Sample  Duration       Occupancy Analysis Results Fungus Cone
No. Data Cain) Location No. HEPi!i  Ist Stage 2nd Stage <cfu/a3>
322 SS072S 31 9202 Hall NA NA MA MA 0.00
323 83072S 30 9216 Rooa 0 no NA NA
0.00
324 320723 30 9216 Hall MA HA lUn 4Un
6.13
325 330722 20 9214 Room O no MA NA 0.00
****£ 320722 30 9214 Hall MA HA lUn 6Un
3.53
*>~*T  220723 20 9212 Room O no MA MA
0.00
322 330723 30 9212 Hail NA NA NA 3Un 3.63
323 330723 30 9220 X NA NA 2Un NA
2.45
330 320723 30 9264 Roon 0 NA NA lUn 1.23
331 320723 30 9264 Room 0 NA NA NA
0.00
332 230723 30 9220 Y NA NA 2Un 2Un
4.90
333 330723 30 9220 Y NA NA lUnlPe 2Unl3Pe 26.93
234 220723 30 9253 Room 0 NA 2Unl32Pe 200Pe 409.55
325 330722 30 9263 Room 1 NA 2Pe 32Pe • 41.69
326 S20723 30 9220 X NA NA 3Unl44Pe 200PelUnlAT 427.94
337 330723 30 9200 Y NA NA 2Un 3Un7Pe 14.71
333 330723 30 9200 Entry MA MA SUn lOUn 22.07
333 330729 30 9200 Entry NA NA 8Un 2UnlAN 13.49
340 330729 30 9200 Y NA NA 3Un 2UnlAM
7.36
341 330729 20 9220 Y NA NA 3Un23Pe IRhlSIPe
213.25
342 330729 30 9220 X HA NA 89Pe 19SPelUn 349.47
343 320729 30 9220 Hall NA NA lUn 5Un2Pe
9.31
344 220729 30 9222 Hall NA NA lUn lUn 2.45
345 320729 30 9264 Room 0 NA lUn IPe 2.45
346 820729 30 9263 Roon 0 NA 2Un lUn 3.68
347 230201 30 9200 Y HA NA 2Un SUn 12.25
342 330201 30 9220 Y NA NA 9Un lAN4Un2Cl 19.62
349 330201 20 9220 X NA NA 12ylUn 5SylAr2Un 12.26
350 230201 30 9263 Room NA NA 3Un lAalRh8Un 15.94
351 220301 30 9215 Room 0 yea NA NA 6.00
352 330301 30 9215 Hall NA NA NA 6Un 7.36
353 380301 20 9213 Room 0 yes NA NA 0.00
354 880301 30 9213 Hall NA NA NA lUn 1.23
355 330301 30 9211 Room 0 yea NA NA
0.00
356 380301 30 9211 Hall NA NA NA NA 0.00
357 380302 30 9207 Room 2 yes NA IPe 1.23
353 830202 30 9207 Hall NA NA NA lA32UnlPe
4.90
359 880802 30 9206 Roon 0 yes NA NA
0.00
360 830302 30 9206 Hall NA MA NA 3Un
3.63
361 880302 30 9205 Room 0 yes NA NA 0.00
362 880302 30 9220 X NA NA NA     ' ' •2AslPe9Un 14.71
363 380302 30 9204 Room 1 yea NA NA 0.00
364 830802 30 9204 Hall NA NA lUn 2Un
3.68
365 880802 30 9203 Room 0 yes NA NA 0.00
366 880302 30 9202 Room 2 yes NA NA 0.00
367 880302 30 9201 Room 3 yes •lUn NA
1.23
368 330302 30 9201 Hall  • NA MA 2Un lUn
3.63
369 380305 30 9200 Entry NA NA lUn SUn
4.90
#Sample   Duration       Occupancy Analysis Results Fungus Cone
No. Date <min> Location No. HEPA 1st Stage 2nd Stage <cfu/n2)
370 aeoeos 20 9200 Y NA NA 4Un 4Un2Cl 12.26
371 asosos 30 9220 Y NA NA 6Un 5Un •' 13.49
372 380305 30 9220 X NA NA 2Un 5Un 8.53
373 880305 30 9233 Room 0 no NA lUn 1.23
374 83OS05 30 9264 Rooa 0 no 3Un 2Un 6.13
375 SS0305 30 9247 Rooa ^ o no lUn NA 1.23
37S SS0SC5 30 9220 Hall MA NA lUn lUn 2.45
377 380305 30.5 9222 Rooa NA no lUn lUn
2.41
373 330305 20 9223 Hall NA NA NA lUn
1.23
379 830305 30 9210 Room 1 yes NA NA 0.00
330 SS0S05 20 9210 Hall NA NA lUn lUn
2.45
231 830303 30 9216 Rooa 0 no NA NA o.oo"
332 3S0S0S 30 9216 Hall NA NA HA NA
0.00
333 330303 30 9214 Rooa 0 no NA NA
0.00
234 330303 20 9214 Hall NA HA 5Un 2Un 3.53
335 830303 30 9212 Rooa 0 no NA "NA - ͣ —0.00
336 SSC30S 20 9212 Hall NA NA lUn lUn
2.45
337 SS080S 20 9263 Rooa 0 no lAB2Un lUr.lAN
6.13
333 380303 ' 30 9264 Rooa 0 no NA 2Un 3.63
289 330303 30 9220 Y NA HA 4Un lPe3Un
9.81
390 380303 30 9220 X NA NA 2Un 3UnlAB
7.36
391 880309' 30 920i Rooa 3 yes lUn lUn 2.45
292 380309 20 9201 Hall NA NA HA 3Un
3.68
393 330309 30 9202 Rooa 1 yes NA NA 0.00
294 8S03C9 30 9203 Rooa 3 yes NA NA 0.00
395 330309 30 9204 Rooa 1 yes NA NA 0.00
396 380309 30 9204 Hall NA NA lUn NA 1.23
397 880309 30 9205 Room 1 yes MA NA 0.00
393 380309 30 9205 Hall NA NA lUn NA 1.23
399 380809 30 9207 Rooa 1 yes NA NA 0.00
400 380309 30 9207 Hall NA NA NA lUn
1.23
401 830809 30 9210 Room 1 yes MA NA O.OO
402 830309 30 9210 Hall NA NA lUn NA 1.23
403 330311 30 9212 Rooa 0 no NA lUn 1.23
404 380311 10 AH32 Roof NA NA O'grn 14Un TMTC
405 380311 11.5 AH32 Roof NA NA O'grn O'grn TMTC
406 830811 30 9212 Rooa 0 no 3Un IAN 4.90
407 330811 11 AH32 Roof NA NA O'grn O'grn TMTC
403 830311 21 AH22 Roof NA NA O'grn O'grn TMTC
409 330311 55.5 9212 Rooa 0 no NA NA O.OO
410 330311 25 AH32 Roof NA NA O'grn • 2AClAN48Un TMTC
411 880811 11 AH32 Roof NA NA 3Un 30Un 127.08
412 880311 14 AH32 Roof NA NA lOUn 2AH26Un 99.85
413 880311 35 9212 Rooa 0 no NA 2Un 2.10
414 880312 30 9200 Entry NA NA 6Un O'grn TMTC
415 380812 30 9200 Y NA NA 2Un 9Un 13.49
416 830312 30 9220 Y NA NA 8Un 2Unl2y *  13.49
417 830312 30 9220 X NA NA NA lUn ' 1.23
413 880812 30 9263 Room 0 no NA lUn V.. 1.23
Sample   Duration        Occupancy    Analysis Results      Fungus Cone.No. Date   <min) Location   No. KEPA Ist Stage  2nd Stage      <c£u/a3 5
419 330812 30 9264 Room O no NA • MA
0.00
420 330312 30 9247 Room 0 no NA 6Un
7.36
421 330312 30 9220 Hall NA NA NA 12Un
14.71
422 330312 30 9206 Room 1 yes lUn 2Un 3.63
422 330312 30 9206 Hall NA NA lUn 2Un
3.63
424 330312 30 9223 Hall MA NA MA lUn 1.23
425 330312 30 9222 Room NA NA HA 2Un
2.45
42S 330314 5 AH31 Roof NA NA 3Un lAN3PelOUn 161.36
427 330314 5 AH32 Roo£ NA MA lOUn lAN9PelUn 154.50
423 330314 5 AH31 Roof NA NA IZylUn 9Pel2UnlAN 176.57
429 330314 5 AH32 Roof NA NA 3PelOUn lPel2y3Un 132.43
420 330314 5 AH21 Roof NA NA SUn 14Un 161.86
421 330314 5 AH32 Roof NA NA lPellUn2Cl lAM6Pe4As7Un 225.43
432 330314 5 AH31 Roof MA NA SUn IPalRh 51.50
423 330314 5 AH22 Roof NA NA 3Un 7Pe4Un8Cl- 161.36 .
434 330314 20.5 9214 Room O no SUn NA 6.03
435 330314 30 9212 Room 0 no MA NA
0.00
43S 330314 30 9212 Room 0 no NA NA 0.00
437 330314 30 9214 Room O no NA NA 0.00
433 330314 30 9246 Room O no NA 2Pe 2.45
439 330314 30 9264 Room 0 no NA NA 0.00
440 330314 5 AH21 Roof NA NA IPeSUn 3Pel3Un
159.22
441- 330314 5 AH32 Roof NA NA IClSUn 5PslAsl3Un 132.93
442 830314 5 AH31 Roof NA HA 6Un 5Pe5Un 117.72
443 330314 5 AH32 Roof NA NA 2Un 6PelAs9Un 132.43
447 3S0S14 5 AH31 Roof MA NA 3Un 12Pel2y22UnlAM 286.93
443 330314 5 AH32 Roof NA NA 3Un 7Pe29Un 286.93
449 830314 5 AH31 Roof NA NA lPe4Un 7PelRhl4Un 193.64
450 330314 5 AH32 Roof MA NA IlUn 9Pel5UnlA3 264.36
451 880315 5 AH31 Roof NA NA NA 4Pel7UnlA3 161.86
452 330315 5 AH32 Roof NA NA 3Un lOUn 95.64
453 330815 5 AH31 Roof NA NA •4Un 4Pe24UnlAs 242.79
454 330315 5 AH32 Roof NA NA 2Pe7Un lPe7Un 125.07
455 380815 5 AH31 Roof NA NA IPellUn 14Un 191.29
45S. 830315 5 AH32 Roof NA NA 2Un 3UnlAs 44.14
457 830315 S AH31 Roof NA NA MA lPe27UnlAN 213.36
453 830315 3 AH32 Roof NANA IPeSUn 6Un 88.29
459 830315 5 AH31 Roof MA NA 4UnlCl 2Un 51.50
460 330315 5 AH32 Roof MA MA lPa6Un 2Pe9Un 132.43
461 330315 5 AH31 Roof MA NA 14Un 2Pe21Un 272.22
462 830315 5 AH32 Roof NA NA 3Un lPel9Un 169.22
463 830315 30 9214 Room O no NA NA
0.00
464 880315 30 9212 Room 0 no NA lUn
1.23
465 830315 30 9214 Room 0 no NA NA
0.00
466 830315 30 9212 Room O no NA MA
0.00
467 330315 30 9246 Room O no NA NA 0.00
468 880315 30.S 9264 Room 0 no lUn 4Un
6.03
Sample   Duration        Occupancy    Analysis Results
No. Data   (min) Location   No. HEPA 1st Stage  2nd Stage
Fungus Cone,
(cfu/m3)
4S9 3S0315
470 3S0S15
471 330315
472 S30315
473 330315
474 330315
475 330315
47S S3C315
5 AH31 Roof NA NA lOUn 32UnlAT 31S,.36
5 AH32 Roo£ NA NA 12Un 22Un2PelAT 272,. 22
5 AH21 Roof NA NA lRh2Un 6Un 66,.21
5 AH32 Roof NA NA SUn 14Un2PelAT lei..29
5 AH31 Roof NA NA . lOUn 12Un4Pe2AT 206,.00
5 AH32 Reef NA NA 7L'r. 7yn 103,,oo
5 AH31 Rcof NA MA lP.23Un 7UnlPelAT 95,.64
AH32 Roof NA NA 7UnlCl SUnlPelCl 110,.36
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^APPENDIX F
#
^•
BWrrU ANALYSIS BY A SINGLE CDMPAKTMENT MODEL
3
Let:  Q  = room inlet airflow rate, supplied by AH-31. (m /hr)
0^2 = airflow rate, supplied by AH-32. (m'^/hr) = 20 Q^^
3
Q  = room HEPA airflow rate, (m /hr) = 3 Q^,r ^ 31
Qj^j = hallway HEPA airflow rate, (m /hr) = 10 Q^^
3
C_^ = AH-31 filtered, inlet spore cone.. (CFU/m )
3
0^2 = AH-32 filtered, inlet spore cone. (CFU/m ) = 7 C^j
E = 1.00. (dimensionless)
G = 0. (CFU/hr)
Equivalent one-compartment variables are:
Q. = BMTU inlet airflow rate, supplied to 16 rooms and hallway
' = 16 ^31 ^ ^32 = 16 ^31 ^ 20 Q31 = 46 03^
Conditions of
AH-31 Supply        C.(CFU/m"^) Q (m"^/hr)
69 C  16 Q.., + C  Qunfiltered        -^^    "^^   "^^ '^^     13(3 Q ) + Q, ,---------------------       *^  rm'   hi
16 Q3I ^ %2
,.,,  ,       Si 16 Q31 + C3J Q32filtered       ___________________ Q,
16 Q3I " ^2
hi
Q. + G
By substitution of simplified equivalents into C = C. ;r----„ ^iQ. +EQ
^ unfilt
f        ^6Q3j          ^
2^-^6 C3^   l^^ Q_^^ ^ ^3 Q_^J 16.73 C^^
^ filter r    ^6Q3i    1   -3-39 Si   [46 Q3^ . 10 Q3J
-    2.79 C3^
= 6.0
iXiring this study, only 13 out of 16 patient rooms had HEPA
filtration. Unfiltered room concentration equals 69 times
C_^ from Table 13 (page 24).
